10-Q

`

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2020

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-36729

FRESHPET, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware	20-1884894
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
400 Plaza Drive, 1st Floor, Secaucus, New Jersey	07094
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (201) 520-4000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock	FRPT	NASDAQ Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

As of May 1, 2020, the registrant had 40,266,181 shares of common stock, $0.001 par value per share, outstanding.

TABLE OF CONTENTS

		Page No.
Part I. Financial Information		4
Item 1.	Financial Statements	4
	Consolidated Balance Sheets	4
	Consolidated Statements of Operations and Comprehensive Income (Loss)	5
	Changes to Statements of Stockholders’ Equity	6
	Consolidated Statements of Cash Flows	7
	Notes to Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Conditions and Results of Operations	17
Item 3.	Quantitative and Qualitative Disclosures About Market Risks	29
Item 4.	Controls and Procedures	30
Part II. Other Information		31
Item 1.	Legal Proceedings	31
Item 1A.	Risk Factors	31
Item 6.	Exhibits	33

2

Forward-Looking Statements

This report contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact included in this report are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “aim,” “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “outlook,” “potential,” “project,” “projection,” “plan,” “intend,” “seek,” “may,” “could,” “would,” “will,” “should,” “can,” “can have,” “likely,” the negatives thereof and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. They appear in a number of places throughout this report and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the industry in which we operate. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected, including:

• our ability to successfully implement our growth strategy;

• our ability to timely complete the construction of our Freshpet Kitchens 2.0, Kitchens South and Kitchens 3.0 (together, the “Freshpet Kitchens expansion projects”) and achieve the anticipated benefits therefrom;

• the effect of the novel coronavirus (“COVID-19”) on our business, employees, suppliers, customers and end consumers;

• the loss of key members of our senior management team;

• allegations that our products cause injury or illness or fail to comply with government regulations;

• the loss of a significant customer;

• the entrance of new competitors into our industry;

• the effectiveness of our marketing and trade spending programs;

• our ability to introduce new products and improve existing products;

• our limited manufacturing capacity;

• the impact of government regulation, scrutiny, warning and public perception;

• the effect of false marketing claims;

• adverse weather conditions, natural disasters, pestilences and other natural conditions affecting our operations;

• our ability to develop and maintain our brand;

• the effect of potential price increases and shortages on the inputs, commodities and ingredients that we require;

• our ability to manage our supply chain effectively;

• our ability to generate sufficient cash flow or raise capital on acceptable terms;

• volatility in the price of our common stock; and

• other factors discussed under the headings “Risk Factors”, “Business” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K and in this report.

While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors and it is impossible for us to anticipate all factors that could affect our actual results. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. You should evaluate all forward-looking statements made in this report in the context of these risks and uncertainties.

3

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

FRESHPET, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Unaudited)

	March 31, 2020			December 31, 2019
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	149,486,159		$	9,471,676
Short-term investments		20,000,000			—
Accounts receivable, net of allowance for doubtful accounts		20,295,397			18,580,840
Inventories, net		16,005,370			12,542,269
Prepaid expenses		2,998,336			3,275,992
Other current assets(1)		10,720,781			10,452,990
Total Current Assets		219,506,043			54,323,767
Property, plant and equipment, net		195,607,774			165,287,597
Deposits on equipment		4,298,520			3,600,931
Operating lease right of use assets		8,846,194			9,154,234
Other assets		3,708,158			3,759,058
Total Assets	$	431,966,689		$	236,125,587
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable	$	20,420,592		$	18,667,729
Accrued expenses(1)		20,440,468			22,132,928
Current operating lease liabilities		1,241,168			1,185,058
Total Current Liabilities	$	42,102,228		$	41,985,715
Long term debt		—			54,466,099
Long term operating lease liabilities		8,069,160			8,409,252
Total Liabilities	$	50,171,388		$	104,861,066
STOCKHOLDERS' EQUITY:
Common stock — voting, $0.001 par value, 200,000,000 shares authorized, 40,271,411 issued and 40,257,242 outstanding on March 31, 2020, and 36,162,433 issued and 36,148,264 outstanding on December 31, 2019		40,271			36,162
Additional paid-in capital		588,357,121			334,299,172
Accumulated deficit		(206,325,650	)		(202,735,417	)
Accumulated other comprehensive income		(20,215	)		(79,170	)
Treasury stock, at cost — 14,169 shares on March 31, 2020 and on December 31, 2019		(256,226	)		(256,226	)
Total Stockholders' Equity		381,795,301			131,264,521
Total Liabilities and Stockholders' Equity	$	431,966,689		$	236,125,587

See accompanying notes to the unaudited consolidated financial statements.

(1) See Note 10 for additional information.

(1)

4

FRESHPET, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

	For the Three Months Ended
	March 31,
	2020			2019
NET SALES	$	70,097,805		$	54,792,202
COST OF GOODS SOLD		38,308,179			28,877,221
GROSS PROFIT		31,789,626			25,914,981
SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES		34,675,943			29,232,250
LOSS FROM OPERATIONS		(2,886,317	)		(3,317,269	)
OTHER INCOME/(EXPENSES):
Other Income/(Expenses), net		21,518			17,295
Interest Expense		(703,834	)		(102,776	)
		(682,316	)		(85,481	)
LOSS BEFORE INCOME TAXES		(3,568,633	)		(3,402,750	)
INCOME TAX EXPENSE		21,600			19,250
LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	$	(3,590,233	)	$	(3,422,000	)
OTHER COMPREHENSIVE INCOME (LOSS):
Change in foreign currency translation	$	58,955			91,047
TOTAL OTHER COMPREHENSIVE INCOME		58,955			91,047
TOTAL COMPREHENSIVE LOSS	$	(3,531,278	)	$	(3,330,953	)
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS
-BASIC	$	(0.10	)	$	(0.10	)
-DILUTED	$	(0.10	)	$	(0.10	)
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING USED IN COMPUTING NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS
-BASIC		37,443,758			35,668,323
-DILUTED		37,443,758			35,668,323

See accompanying notes to the unaudited consolidated financial statements.

5

FRESHPET, INC. AND SUBSIDIARIES

CHANGES TO STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited)

	Common Stock - Voting													Treasury Stock
	Number of Shares Issued		Amount		Additional Paid-in Capital			Accumulated Deficit			Accumulated Other Comprehensive Income			Number of Shares		Amount			Total Stockholders' Equity
BALANCES, December 31, 2019		36,162,433	$	36,162	$	334,299,172		$	(202,735,417	)	$	(79,170	)		14,169	$	(256,226	)	$	131,264,521
Exercise of options to purchase common stock		44,156		44		402,512			—			—			—		—			402,556
Issuance of restricted stock units		64,823		65		(644,664	)		—			—			—		—			(644,599	)
Share-based compensation expense		—		—		2,241,847			—			—			—		—			2,241,847
Shares issued in primary offering		3,999,999		4,000		252,058,254			—			—			—		—			252,062,254
Foreign Currency Translation		—		—		—			—			58,955			—		—			58,955
Net loss		—		—		—			(3,590,233	)		—			—		—			(3,590,233	)
BALANCES, March 31, 2020		40,271,411	$	40,271	$	588,357,121		$	(206,325,650	)	$	(20,215	)		14,169	$	(256,226	)	$	381,795,301

	Common Stock - Voting													Treasury Stock
	Number of Shares Issued		Amount		Additional Paid-in Capital			Accumulated Deficit			Accumulated Other Comprehensive Income			Number of Shares		Amount			Total Stockholders' Equity
BALANCES, December 31, 2018		35,556,595	$	35,556	$	323,079,437		$	(201,352,682	)	$	(31,610	)		14,169	$	(256,226	)	$	121,474,475
Exercise of options to purchase common stock		248,195		248		1,791,420			—			—			—		—			1,791,668
Issuance of restricted stock units		61,532		62		(673,836	)		—			—			—		—			(673,774	)
Share-based compensation expense		—		—		1,260,126			—			—			—		—			1,260,126
Foreign Currency Translation		—		—		—			—			91,047			—		—			91,047
Net loss		—		—		—			(3,422,000	)		—			—		—			(3,422,000	)
BALANCES, March 31, 2019		35,866,322	$	35,866	$	325,457,147		$	(204,774,682	)	$	59,437			14,169	$	(256,226	)	$	120,521,542

See accompanying notes to the unaudited consolidated financial statements.

6

FRESHPET, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	For the Three Months Ended
	March 31,
		2020			2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(3,590,233	)	$	(3,422,000	)
Adjustments to reconcile net loss to net cash flows provided by operating activities:
Provision for loss/(gains) on accounts receivable		90,712			28,778
Loss on disposal of equipment		1,662			8,028
Share-based compensation		2,178,214			1,200,336
Inventory obsolescence		117,937			10,238
Depreciation and amortization		4,453,031			3,720,091
Amortization of deferred financing costs and loan discount		625,299			28,775
Changes in operating assets and liabilities:
Accounts receivable		(1,805,269	)		(5,010,252	)
Inventories		(3,581,038	)		(1,802,222	)
Prepaid expenses and other current assets		9,865			(929,849	)
Operating lease right of use		308,040			241,785
Other assets		11,786			(36,010	)
Accounts payable		655,688			2,555,681
Accrued expenses		(1,692,460	)		(832,986	)
Other lease liabilities		(283,982	)		(217,469	)
Net cash flows used in operating activities		(2,500,748	)		(4,457,076	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of short-term investments		(20,000,000	)		—
Acquisitions of property, plant and equipment, software and deposits on equipment		(34,237,980	)		(10,453,923	)
Net cash flows used in investing activities		(54,237,980	)		(10,453,923	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from common shares issued in primary offering, net of issuance cost		252,062,254			—
Proceeds from exercise of options to purchase common stock		402,556			1,791,668
Tax withholdings related to net shares settlements of restricted stock units		(644,599	)		(673,774	)
Proceeds from borrowings under Credit Facilities		20,933,000			10,000,000
Repayment of borrowings under Credit Facilities		(76,000,000	)		—
Net cash flows provided by financing activities		196,753,211			11,117,894
NET CHANGE IN CASH AND CASH EQUIVALENTS		140,014,483			(3,793,105	)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR		9,471,676			7,554,388
CASH AND CASH EQUIVALENTS, END OF PERIOD	$	149,486,159		$	3,761,283
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	$	766,950		$	29,717
NON-CASH FINANCING AND INVESTING ACTIVITIES:
Property, plant and equipment purchases in accounts payable	$	8,671,690		$	463,546
Non-cash acquisitions of property, plant and equipment	$	—		$	1,749,901

See accompanying notes to the unaudited consolidated financial statements.

7

FRESHPET, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 – Nature of the Business and Summary of Significant Accounting Policies:

Nature of the Business – Freshpet, Inc. (hereafter referred to as “Freshpet” the “Company”, “we” or “our”), a Delaware corporation, manufactures and markets natural fresh meals and treats for dogs and cats. The Company’s products are distributed throughout the United States and other international markets, into major retail classes including Grocery (including online), Mass and Club, Pet Specialty, and Natural retail.

Basis of Presentation – The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”). The unaudited consolidated financial statements include the accounts of the Company as well as the Company’s wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The interim unaudited consolidated financial statements have been prepared on the same basis as the annual audited consolidated financial statements and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). In the opinion of management, the interim unaudited financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of March 31, 2020, the results of its operations and changes to stockholders’ equity for the three months ended March 31, 2020 and 2019, and its cash flows for the three months ended March 31, 2020 and 2019. The results for the three months ended March 31, 2020 are not necessarily indicative of results to be expected for the year ending December 31, 2020, or any other interim periods, or any future year or period. Certain amounts that appear in this report may not add up because of differences due to rounding.

These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes in Item 8 of Part II, “Financial Statements and Supplementary Data,” of our Annual Report on Form 10-K for the year ended December 31, 2019.

Estimates and Uncertainties – The preparation of our consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results, as determined at a later date, could differ from those estimates.

Fair Value of Financial Instruments – Financial Accounting Standards Board (“FASB”) guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).

The three levels of the fair value hierarchy are as follows:

• Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities.

• Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 2 includes financial instruments that are valued using models or other valuation methodologies.

• Level 3 – Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when their fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable.

8

FRESHPET, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The carrying amounts reported in the balance sheets for cash and cash equivalents, short-term investments, other receivables, accounts payable and accrued expenses approximate their fair value based on the short-term maturity of these instruments.

As of March 31, 2020, the Company only maintained Level 1 assets and liabilities.

Short-Term Investments – The Company holds interest-bearing certificates of deposits with financial institutions with maturities ranging from three months to one year. Certificates of deposit are classified as short-term investments and interest is recorded as other income.

Restricted Stock Tax Withholdings – To meet payroll tax withholdings obligations arising from the vesting of restricted share units, the Company withheld 10,077 shares totaling $0.7 million, for the three month period ended March 31, 2019. Shares of common stock withheld for tax withholdings do not reduce the Company’s total share repurchase authority.

Debt Issuance Cost – During 2019, the Company incurred $1.1 million of fees associated with the debt modification, of which $0.7 million were paid to the creditor. Further, the Company noted that $0.7 million of the fees were related to the Draw Term Loan with the remaining balance relating to the Revolving Loan Facility. The Company’s policy is to record the debt issuance cost related to the Draw Term Loan, net of debt, for the portion of the Draw Term Loan that is outstanding, with the remaining amount recorded within assets. As of March 31, 2020, the Company paid the outstanding balance of the Draw Term Loan and wrote down $0.6 million of the related fees. As of March 31, 2020, there was $0.5 million of debt issuance cost that were recorded to other assets and less than $0.1 million was recorded to other current assets.  

The Company amortizes debt issuance costs categorized as assets on a straight-line basis over the term of the loan, and amortizes the debt issuance costs that are categorized net of debt using the effective interest method, over the term of the loan.

Information about the Company’s net sales by class of retailer is as follows:

	Three Months Ended
	March 31,
	2020		2019
Grocery (including Online), Mass and Club	$	60,818,851	$	45,707,897
Pet Specialty and Natural		9,278,954		9,084,305
Net Sales	$	70,097,805	$	54,792,202

Recently Issued Accounting Standards

In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard requires an entity to utilize a new impairment model known as the current expected credit loss (“CECL”) model to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. The new guidance is effective for financial statements issued for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The reported results for the three months ended March 31, 2020 reflect the application of ASU 2016-13. The application of the update did not have a material impact to our reserve for accounts receivable. Please see the description of the Company’s “Trade accounts receivable” accounting policy below.

9

FRESHPET, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Trade accounts receivable – The allowance for doubtful accounts is based on the Company’s assessment of the collectability of customer accounts. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the accounts receivable balances and current economic conditions that may affect a customer’s ability to pay.

Note 2 – Inventories:

	March 31,			December 31,
	2020			2019
Raw Materials and Work in Process	$	4,184,814		$	4,453,498
Packaging Components Material		1,869,166			1,419,155
Finished Goods		10,092,896			6,842,359
		16,146,876			12,715,012
Reserve for Obsolete Inventory		(141,506	)		(172,743	)
	$	16,005,370		$	12,542,269

Note 3 – Property, Plant and Equipment:

	March 31,			December 31,
	2020			2019
Refrigeration Equipment	$	102,591,520		$	97,568,137
Machinery and Equipment		68,781,746			54,274,118
Building, Land, and Improvements		25,621,495			25,621,495
Furniture and Office Equipment		4,969,901			4,931,703
Leasehold Improvements		395,241			395,241
Automotive Equipment		309,137			309,137
Construction in Progress		73,702,188			58,587,375
		276,371,228			241,687,206
Less: Accumulated Depreciation		(80,763,454	)		(76,399,609	)
	$	195,607,774		$	165,287,597

Depreciation expense related to property, plant and equipment totaled $4,372,792 for the three months ended March 31, 2020, of which $1,743,657 was recorded to cost of goods sold for the three months ended March 31, 2020, with the remainder of depreciation and amortization expense recorded to selling, general and administrative expense. 

Depreciation expense related to property, plant and equipment totaled $3,643,492 for the three months ended March 31, 2019, of which $1,566,088 was recorded to cost of goods sold for the three months ended March 31, 2019, with the remainder of depreciation and amortization expense recorded to selling, general and administrative expense.

10

FRESHPET, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 4 – Accrued Expenses:

	March 31,		December 31,
	2020		2019
Legal Contingency (1)		10,310,000		10,100,000
Accrued Compensation and Employee Related Costs		4,033,898		6,390,692
Accrued Chiller Cost		1,548,752		1,576,214
Accrued Customer Consideration		735,172		635,399
Accrued Freight		726,381		702,673
Accrued Production Expenses		1,801,527		413,550
Accrued Marketing		595,376		1,187,885
Other Accrued Expenses		689,362		1,126,515
	$	20,440,468	$	22,132,928

(1) See Note 10 for additional information.

Note 5 – Debt:

On May 15, 2019, the Company entered into the Fourth Amended and Restated Loan and Security Agreement (as amended, the “Loan Agreement”), which amended and restated in full the Company’s Third Amended and Restated Loan and Security Agreement, dated as of September 21, 2017. The Loan Agreement provided for a $90 million senior secured credit facility (the “Credit Facility”), encompassing a $55.0 million delayed draw term loan facility (the “Draw Facility”) and a $35.0 million revolving loan facility (the “Revolving Loan Facility”). The Company had the ability to increase the Credit Facility by up to an additional $75.0 million, subject to certain conditions.

The Credit Facility was scheduled to mature on May 15, 2024 and borrowings thereunder accrued interest at variable rates depending on the Company’s election, either at a base rate or at LIBOR, in each case, plus an applicable margin. Subject to the Company’s leverage ratio, the applicable margin varied between 0.50% and 1.00% for base rate loans and 1.50% and 2.00% for LIBOR loans. Upon closing the Credit Facility, the Company borrowed $15.0 million under the Revolving Loan Facility, which left $20.0 million of availability. The Company had the option to borrow term loans under the Draw Facility (“Draw Term Loans”) until May 15, 2021, subject to certain conditions.

Borrowings under the Credit Facility were secured by substantially all of the Company’s and certain of its subsidiaries’ assets. The Loan Agreement required compliance with various covenants customary for agreements of this type, including financial covenants and negative covenants that limit, among other things, the Company’s ability to incur additional debt, create or incur liens, engage in mergers or consolidations, sell, transfer or otherwise dispose of assets, make voluntary prepayments to subordinated debt, permit a change of control, pay dividends or distributions, make investments, and enter into certain transactions with affiliates. The Loan Agreement also included events of default customary for agreements of this type.

As of March 31, 2020, the Company had no debt outstanding under the Credit Facilities. During the first quarter of 2020, borrowings under the Credit Facilities totaled $20.9 million that consisted of $13.9 million related to Draw Term Loans, net of unamortized debt issuance cost of less than $0.1 million, and $7.0 million related to the Revolving Loan Facility. Net borrowings under the Credit Facilities totaled $54.5 million at December 31, 2019, of which $40.5 million net of unamortized debt issuance cost of $0.6 million, related to the Draw Term Loans and $14.0 million related to the Revolving Loan Facility.

Interest expense and fees totaled $0.7 million for the three months ended March 31, 2020, of which $0.6 million was related to the recognition of debt issuance fees due to the repayment of the Draw Term Loan. Interest expense and fees totaled $0.1 million for the three months ended March 31, 2019.

In 2019, the Company incurred $1.1 million of debt issuance cost upon execution of the Credit Facility. As of March 31, 2020, the Company paid the outstanding balance of the Draw Term Loan and wrote down $0.6 million of the related debt

11

FRESHPET, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

issuance fees that were recognized as interest expense. As of March 31, 2020, $0.5 million of the remaining debt issuance cost was recorded to other assets and less than $0.1 million was recorded to other current assets.

Note 6– Leases:

We have various noncancellable lease agreements for office and warehouse space, as well as office equipment, with original remaining lease terms of two years to nine years, some of which include an option to extend the lease term for up to five years. Because the Company is not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term, and associated potential option payments are excluded from lease payments. The Company’s leases generally do not include termination options for either party to the lease or restrictive financial or other covenants.

Weighted-average remaining lease term (in years) and discount rate related to operating leases were as follows:

Weighted-average remaining lease term	5.99
Weighted-average discount rate	6.14	%

As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the date of adoption to determine the present value of lease payments.

Maturities of lease liabilities under noncancellable operating leases as of March 31, 2020 were as follows:

	March 31, 2020
2020 (a)		1,319,802
2021		1,768,626
2022		1,763,787
2023		1,802,007
2024		1,511,214
2024 and beyond		2,786,004
Total lease payments		10,951,440
Less: Imputed interest		(1,641,112	)
Present value of lease liabilities	$	9,310,328

(a) Excluding the three months ended March 31, 2020.

A summary of rent expense for the three months ended March 31, 2020 and 2019 was as follows:

12

FRESHPET, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

	For the Three Months Ended
	March 31,
	2020		2019
Operating lease cost	$	452,155	$	256,882

Supplemental cash flow information and non-cash activity relating to operating leases are as follows:

	For the Three Months Ended March 31,
	2020		2019
Operating cash flow information:
Cash paid for amounts included in the measurement of lease liabilities	$	283,982	$	246,735

Note 7 – Equity Incentive Plans:

Total compensation cost for share-based payments recognized for the three months ended March 31, 2020 and 2019 is $2,241,847 and $1,260,126, respectively.

2010 Stock Plan—The outstanding options are time-based (vest between two and four years). At March 31, 2020, there were zero shares available for grant as the 2010 Plan is frozen. The total number of unexercised options for the 2010 Plan is 256,890.

2014 Omnibus Incentive Plan—In November 2014, the Company approved the 2014 Omnibus Incentive Plan (the “2014 Plan”). Under the 2014 Plan, 2,644,133 shares of common stock may be issued or used for reference purposes as awards granted. These awards may be in the form of stock options, stock appreciation rights, restricted stock, as well as other stock-based and cash-based awards. At March 31, 2020, the awards granted were either time-based, performance-based (vest when performance targets are met, as defined in the stock option grant agreement), or restricted stock units (employee RSUs vest over three years or cliff vest (as defined in the restricted stock agreement) and non-employee director RSUs vest over one year). The total number of unexercised options and RSUs for the 2014 Plan is 2,644,133.

At March 31, 2020, there were 1,457,834 shares of common stock available to be issued or used for reference purposes under the 2014 Plan.

NASDAQ Marketplace Rules Inducement Award—During fiscal year 2016 and the first quarter of 2020, share-based awards were granted to the Company’s Chief Executive Officer and the Executive Vice President of Finance, respectively, as an inducement under the NASDAQ Marketplace Rules, and therefore outside of any Plan. Under the terms of the agreement, the grant is governed as if issued under the 2014 Omnibus Plan. As of March 31, 2020, the awards granted were time-based (cliff vest over four years) and performance-based (vest when performance targets are met, as defined in the stock option grant agreement).

Service Period Stock Options

The following table includes activity related to outstanding service period stock options during the three months ended March 31, 2020.

13

FRESHPET, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Service Period Stock Options	Shares			Weighted Average Exercise Price
Outstanding at December 31, 2019		1,359,990		$	11.50
Granted		15,000			60.10
Exercised		(44,156	)		9.11
Forfeited		(357	)		11.00
Outstanding at March 31, 2020		1,330,477		$	12.13

Performance-Vested Stock Options

The following table includes activity related to outstanding performance-vested stock options during the nine months ended March 31, 2020.

Performance Based Options	Shares		Weighted Average Exercise Price
Outstanding at December 31, 2019		1,372,819	$	18.31
Granted		—		—
Exercised		—		—
Forfeited		—		—
Outstanding at March 31, 2020		1,372,819	$	18.31

As of March 31, 2020, 1,303,361 performance-vested stock options at a weighted average exercise price of $18.50 have performance metrics that are probable of achievement. These shares are included in share-based compensation costs for the three months ended March 31, 2020.

Restricted Stock Units

The following table includes activity related to outstanding restricted stock units during the three months ended March 31, 2020.

Restricted Stock Units	Shares			Weighted-Average Grant-Date Fair Value Per Unit
Outstanding at December 31, 2019		240,229		$	29.07
Granted		5,280			62.88
Issued upon vesting		(32,727	)		17.56
Forfeited		(604	)		32.83
Outstanding at March 31, 2020		212,178		$	31.68

Note 8 – Net Loss Per Share Attributable to Common Shareholder:

Basic net loss per share of common stock is calculated by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. Diluted net loss per share of common stock is computed by giving effect to all potentially dilutive securities.

For the three months ended March 31, 2020 and 2019, there were no adjustments between net loss and net loss attributable to common stockholders.

14

FRESHPET, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The potentially dilutive securities are as follows:

	Three Months Ended
	March 31,
	2020		2019
Service Period Stock Options		1,355,853		1,686,048
Restricted Stock Units		241,582		249,252
Performance Stock Options		34,482		59,693
Total		1,631,917		1,994,993

For the three months ended March 31, 2020 and 2019, diluted net loss per share of common stock is the same as basic net loss per share of common stock, due to the fact that potentially dilutive securities would have an antidilutive effect as the Company incurred a net loss during such periods.

Note 9 – Concentrations:

Concentration of Credit Risk—The Company maintains its cash balances in financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 each. At times, such balances may be in excess of the FDIC insurance limit.

Note 10 – Commitments and Contingencies:

A securities lawsuit, Curran v. Freshpet, Inc. et al, Docket No. 2:16-cv-02263, was instituted on April 21, 2016 in the United States District Court for the District of New Jersey against the Company and certain of the Company’s current and former executive officers and directors on behalf of certain purchasers of our common stock. The plaintiffs sought to recover damages for investors under the federal securities laws.  On October 3, 2019, the parties filed with the District Court a motion for preliminary approval of settlement that attached the parties’ stipulation of settlement and a proposed order. The settlement funds due, held in escrow, were paid by the Company’s insurers, and the District Court approved the Final Judgment and Order of Dismissal with Prejudice on March 11, 2020 with a 30 day option to appeal.  As of March 31, 2020, the Company accrued for an estimated probable loss of $10.1 million, which represents the settlement amount and accrued legal fees. The Company concluded that the insurance recovery is probable and recorded a gain contingency of $10.1 within other current assets. There was no appeal taken within 30 days from the entry of the Judgment. The Judgment was Effective April 10, 2020.

A shareholder derivative lawsuit, Meldon v. Freshpet, Inc. et al, Docket No. 2:18-cv-10166, was instituted June 5, 2018 in the United States District Court for the District of New Jersey against us and certain of our current and former executive officers and directors on behalf of certain holders of our common stock. We were served with a copy of the complaint in June 2018. The plaintiffs seek to recover damages for investors based on state law claims (alleged breaches of fiduciary duty, waste, and unjust enrichment) in connection with the alleged violations of federal securities laws alleged in the Curran action. On April 3, 2019, the Court granted a stay of the Meldon case pending (i) the close of expert discovery in the Curran action or (ii) the dismissal with prejudice of the Curran action. The parties then entered into settlement discussions, after which the parties reached an agreement in principle to settle the case based on the Company’s commitment to continue certain governance practices. The parties also reached agreement on attorneys’ fees. The settlement is subject to court approval. All parties believe that the agreement in principle to settle the dispute is in their respective best interests in order to avoid the risk, uncertainty, and costs associated with litigation. The parties are in the process of finalizing the settlement documents for submission to the District Court. As of March 31,2020, the Company accrued for an estimated probable loss of $0.2 million, which represents the proposed settlement and accrued legal fees. The Company concluded that the insurance recovery is probable and recorded a gain contingency of $0.2 million within other current assets.

15

FRESHPET, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 11 – Subsequent Events:

The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued for recognitions or disclosures and no events have occurred that require disclosure, except for the following:

On April 17, 2020 the Company amended its  senior secured credit facility (the “New Credit Facility”). This New Credit Facility of $165.0 million, includes a $130.0 million delayed draw term loan facility and a $35.0 million revolving loan facility. The New Credit Facilities replaces the Company’s prior $55.0 million delayed draw term loan facility and $35.0 million revolving loan facility. The New Credit Facility will mature on April 17, 2025.

Based upon further evaluation, the Company did not identify any additional recognized or unrecognized subsequent events that have required adjustment or disclosure in the financial statements.

16

Item 2. Management’s Discussion and Analysis of Financial Conditions and Results of Operations

The following discussion summarizes the significant factors affecting our consolidated operating results, financial condition, liquidity and cash flows as of and for the periods presented below. The following discussion and analysis should be read in conjunction with the accompanying unaudited consolidated financial statements and related notes in Item 1 and with the audited consolidated financial statements and the related notes included in our Annual Report on Form 10-K.

In addition to historical information, this discussion and analysis contains forward-looking statements based on current expectations that involve risks, uncertainties and assumptions, such as our plans, objectives, expectations, and intentions set forth under the sections entitled "Forward-Looking Statements" in this report and "Risk Factors" in our Annual Report on Form 10-K. Our actual results and the timing of events may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in the section entitled "Risk Factors" in our Annual Report on Form 10-K.

For information regarding our consolidated operating results, financial condition, liquidity and cash flows for the three months ended March 31, 2019 as compared to the same period in 2018, refer to "Part I—Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2019, filed with the SEC on May 7, 2019, which information is incorporated herein by reference.

Overview

We started Freshpet with a single-minded mission to bring the power of real, fresh food to our dogs and cats. We were inspired by the rapidly growing view among pet owners that their dogs and cats are a part of their family, leading them to demand healthier pet food choices. Since our Company’s inception in 2006, we have created a comprehensive business model to deliver wholesome pet food that pet parents can trust, and in the process we believe we have become one of the fastest growing pet food companies in North America. Our business model is difficult for others to replicate and we see significant opportunity for future growth by leveraging the unique elements of our business, including our brand, our product know-how, our Freshpet Kitchens, our refrigerated distribution, our Freshpet Fridge and our culture.

Recent Developments

Preliminary Observations on the Effects of COVID-19

In December 2019, a novel coronavirus disease (“COVID-19”) was reported and in January 2020, the World Health Organization (“WHO”) declared it a Public Health Emergency of International Concern. In late February 2020, the WHO raised its assessment of the COVID-19 threat from high to very high at a global level due to the continued increase in the number of cases and affected countries, and in March 2020, the WHO characterized COVID-19 as a pandemic.

Due to COVID-19 our retail customers, in the US, UK and Canada, especially in Grocery and Mass, experienced a surge in consumption as consumers stocked up on food and necessities towards the second half of Q1 2020. The unexpected surge in consumption caused a spike in orders which at times was greater than our production capacity. This caused instances in which we were not able to ship 100% of the orders placed in the first quarter, which was not unusual for consumer packaged goods companies during March. The surge in consumption lasted through early April. During the second quarter, we expect to catch up to the surge in demand we experienced during the first quarter.  

As noted above, the increased surge in consumption exceeded our production capacity during Q1 2020. In order to address the surge in demand and begin to rebuild trade inventories in the second quarter, the Company is making investments designed to protect its team members. These efforts include taking the temperature of every team member before entering the Kitchens, installing increased space for social distancing, instituting staggered shifts, enhancing daily sanitation efforts and weekly deep cleaning of all common areas, requiring use of face coverings by all employees, and limiting access and administering a health check on all visitors. Additionally, the Company suspended its absenteeism policy – and brought in incremental staffing to meet demand – so that any team member who does not feel well does not feel compelled to show up for work. Our Freshpet Kitchens manufacturing facility in Bethlehem, PA is under an exemption included in the Governor of Pennsylvania’s order to close all non-life sustaining businesses. The order specifically exempts “animal food manufacturing” from the closure order.

17

As we look at the implications of COVID-19 on our business over the next 6-12 months there is a lot of uncertainty, including our ability to execute on planned Freshpet Fridge placements and new product listings. Although there is uncertainty about the timing of Fridge placements and new product listing, advertising drives a significant majority of our growth. Our ability to advertise has not been impacted, and as the pandemic causes media rates to go down, there is opportunity for more efficient advertising spend. Further, our consumer demand has remained consistent, and we have not relied on retailer discounting or promotional activity to drive volume or trial.

Additionally, we are unsure how long we will be required to absorb significantly higher costs to protect and reward our employees while simultaneously ensuring we can support our pet parents. We are also monitoring our supply of raw materials and ingredients and packaging materials. Although we have not experienced any extended interruptions to date and our chicken prices for the year are fixed contractually, subject to limited exceptions, we have used our secondary suppliers with increased frequency.  

Based on information available to us as of the date of this report and the investments we made that are noted above, we believe we will be able to start rebuilding trade inventories in the second quarter and once again continue to deliver our products to meet customer orders on a timely basis. We continue to monitor the retail environment and pet parent demand, and intend to adapt as needed to continue to drive growth and meet our goal of “changing the way we feed our pets forever” during the evolving COVID-19 pandemic.

Our current preliminary observations on the effects of COVID-19 assumes there is not a material change to customer operations, consumer purchasing behavior, or unexpected changes to our supply chain over the remainder of the year due to the COVID-19 situation. See the important information in Item 1A. “Risk Factors” below, under the caption “The COVID-19 outbreak has had a material impact on the U.S. and global economies and could have a material adverse impact on our employees, suppliers, customers and end consumers, which could adversely and materially impact our business, financial condition and results of operations.”

Supporting Freshpet’s Growth –

At the Company’s February 2020 Investor Day. Freshpet’s updated strategic plan was presented – “Feed the Growth – 5 by 2025”. The strategic plan looks to add 5 million more households by 2025. To support the strategic plan Freshpet is committed to invest in production capacity as well as upgrades to our systems and processes. During 2020 the investments related to capacity upgrades include:

• Full Conversion of Freshpet Kitchens to Seven-Day Production - During January of 2020, the Company completed the full conversion to seven-day production across all four manufacturing lines at Freshpet Kitchens by converting its final and fourth line to seven-day production.  

• Opening of Kitchens South – The Company completed its investment of approximately $15.0 million at a manufacturing facility titled “Kitchens South” which cooked its first meal in February 2020.

• Freshpet Kitchens 2.0 - The Company has continued to build a 90,000 square-foot addition to our manufacturing location. Freshpet Kitchens 2.0 will make greater use of automation to improve quality, safety and reduce costs. Production start-up is slated for the second half of 2020. Of the expected approximate $110.0 million investment, we have invested approximately $57.5 million on the project to date, with approximately $20.4 million invested during 2020.

• Freshpet Kitchens 3.0 - Located in Ennis, Texas on 74 acres, the initial design and engineering phase has begun. We expect initial production to begin by the fourth quarter of 2022. The Company expects, over time, to install at least seven production lines. Each line is expected to produce approximately $100.0 million in net sales.

Additionally, the Company is upgrading its enterprise resource planning (“ERP”) system.  The project commenced in Q1 2020 with due diligence regarding software selection.  The project is expected to run through Q4 of 2021.

18

In order to fund the strategic capital investments as well as provide the Company with capital flexibility, the Company performed a primary equity offering which provided proceeds of $252.1 million and amended its Credit Facility which increased available debt by $130.0 million.  

To help fund the Company’s strategic capital investments, on March 2, 2020, the Company completed a primary equity offering pursuant to which the Company issued and sold 3,999,999 shares of its common stock to the underwriters of such offering for net proceeds of approximately $252.1 million.

In addition, on April 17, 2020, the Company entered into a Fifth Amended and Restated Loan and Security Agreement with City National Bank, as the arranger and administrative agent, and the other lenders party thereto (the “New Loan Agreement”). The New Loan Agreement provides for a $165.0 million senior secured credit facility (the “New Credit Facility”), encompassing a $130.0 million delayed draw term loan facility (the “New Delayed Draw Facility”) and a $35.0 million revolving loan facility (the “New Revolving Loan Facility”), which replaces the Company’s prior $55.0 million delayed draw term loan facility and $35.0 million revolving loan facility.

The Company intends to use the net proceeds from the primary equity offering, borrowings from the New Credit Facility and cash from operations to continue to fund the Freshpet Kitchens expansion projects.

Components of our Operating Results

Net Sales

Our net sales are derived from the sale of pet food to our customers, who purchase either directly from us or through third-party distributors. Our products are sold to consumers through a fast-growing network of company-owned branded refrigerators, known as Freshpet Fridges, located in our customers’ stores. We continue to roll out Freshpet Fridges at leading retailers across North America and parts of Europe and have installed Freshpet Fridges in approximately 21,900 retail stores as of March 31, 2020. Our products are sold under the Freshpet brand name with ingredients, packaging and labeling customized by class of retail. Sales are recorded net of discounts, slotting, returns and promotional allowances.

Our net sales growth is driven by the following key factors:

• Increasing sales velocity from the average Freshpet Fridge due to increasing awareness, trial and adoption of Freshpet products and innovation. Our investments in marketing and advertising help to drive awareness and trial at each point of sale.

• Increased penetration of Freshpet Fridge locations in major classes of retail, including Grocery (including online), Mass, Club, Pet Specialty, and Natural. The impact of new Freshpet Fridge installations on our net sales varies by retail class and depends on numerous factors including store traffic, refrigerator size, placement within the store, and proximity to other stores that carry our products.

• Consumer trends including growing pet ownership, pet humanization and a focus on health and wellness.

We believe that as a result of the above key factors, we will continue to penetrate the pet food marketplace and increase our share of the pet food category.

Gross Profit

Our gross profit is net of costs of goods sold, which include the costs of product manufacturing, product ingredients, packaging materials and inbound freight.

Our gross profit margins are also impacted by the cost of ingredients, packaging materials, and labor and overhead and share-based compensation related to direct labor and overhead. We expect to mitigate any adverse movement in input costs through a combination of cost management and price increases.

Selling, General and Administrative Expenses

Our selling, general and administrative expenses consist of the following:

Outbound freight. We use a third-party logistics provider for outbound freight that ships directly to retailers as well as third-party distributors.

19

Marketing & advertising. Our marketing and advertising expenses primarily consist of national television media, digital marketing, social media and grass roots marketing to drive brand awareness. These expenses may vary from quarter to quarter depending on the timing of our marketing and advertising campaigns. Our Feed the Growth initiative will focus on growing the business through increased marketing investments.

Freshpet Fridge operating costs. Freshpet Fridge operating costs consist of repair costs and depreciation. The purchase and installation costs for new Freshpet Fridges are capitalized and depreciated over the estimated useful life. All new refrigerators are covered by a manufacturer warranty for three years. We subsequently incur maintenance and freight costs for repairs and refurbishments handled by third-party service providers.

Research & development. Research and development costs consist of expenses to develop and test new products. The costs are expensed as incurred.

Brokerage. We use third-party brokers to assist with monitoring our products at the point-of-sale as well as representing us at headquarters for various customers. These brokers visit our retail customers’ store locations to ensure items are appropriately stocked and maintained.

Share-based compensation. We account for all share-based compensation payments issued to employees, directors and non-employees using a fair value method. Accordingly, share-based compensation expense is measured based on the estimated fair value of the awards on the grant date. We recognize compensation expense for the portion of the award that is ultimately expected to vest over the period during which the recipient renders the required services to us using the straight-line single option method.

Other general & administrative costs. Other general and administrative costs include non-plant personnel salaries and benefits, as well as corporate general & administrative costs.

Income Taxes

We had federal net operating loss (“NOL”) carry forwards of approximately $198.1 million as of December 31, 2019, of which, approximately $175.0 million, generated in 2017 and prior, will expire between 2025 and 2037. The NOL generated in 2018 and 2019, of approximately $23.1 million, will have an indefinite carryforward period but can generally only be used to offset 80% of taxable income in any particular year. The Company may be subject to the net operating loss utilization provisions of Section 382 of the Internal Revenue Code(the “Code”). The effect of an ownership change would be the imposition of an annual limitation on the use of NOL carry forwards attributable to periods before the change. The amount of the annual limitation depends upon the value of the Company immediately before the change, changes to the Company’s capital during a specified period prior to the change, and the federal published interest rate. Although we have not completed an analysis under Section 382 of the Code, it is likely that the utilization of the NOLs will be limited. At December 31, 2019, we had approximately $160.0 million of state NOLs, which expire between 2020 and 2039. At December 31, 2019, we had a full valuation allowance against our net deferred tax assets as the realization of such assets was not considered more likely than not.

Consolidated Statements of Operations and Comprehensive Loss

	Three Months Ended March 31,
	2020						2019
	Amount			% of Net Sales			Amount			% of Net Sales
	(Dollars in thousands)
Net sales	$	70,098			100	%	$	54,792			100	%
Cost of goods sold		38,308			55			28,877			53
Gross profit		31,790			45			25,915			47
Selling, general and administrative expenses		34,676			50			29,232			53
Loss from operations		(2,886	)		(4	)		(3,317	)		(6	)
Other income/(expenses), net		21			0			17			0
Interest expense		(704	)		(1	)		(103	)		(0	)
Loss before income taxes		(3,569	)		(5	)		(3,403	)		(6	)
Income tax expense		21			0			19			0
Net loss	$	(3,590	)		(5	)%	$	(3,422	)		(6	)%

20

Three Months Ended March 31, 2020 Compared to Three Months Ended March 31, 2019

Net Sales

The following table sets forth net sales by class of retailer:

	Three Months Ended March 31,
	2020							2019
	Amount		% of Net Sales			Store Count		Amount		% of Net Sales			Store Count
	(Dollars in thousands)
Grocery (including Online), Mass and Club (1)	$	60,819		87	%		16,686	$	45,708		83	%		14,786
Pet Specialty and Natural (2)		9,279		13			5,181		9,084		17			5,267
Net Sales		70,098		100	%		21,867	$	54,792		100	%		20,053

(1)Stores at March 31, 2020 and March 31, 2019 consisted of 11,614 and 10,231 Grocery and 5,072 and 4,555 Mass and Club, respectively.

(2)Stores at March 31, 2020 and March 31, 2019 consisted of 4,722 and 4,842 Pet Specialty and 459 and 425 Natural, respectively.

Net sales increased $15.3 million, or 27.9%, to $70.1 million for the three months ended March 31, 2020 as compared to the same period in the prior year. The $15.3 million increase in net sales was driven by growth of $15.1 million in our Grocery (including Online), Mass, and Club refrigerated channel and $0.2 million in our Pet Specialty and Natural refrigerated channel. Our Freshpet Fridge store locations grew by 9.0% to 21,867 as of March 31, 2020 compared to 20,053 as of March 31, 2019.

Gross Profit

Gross profit increased $5.9 million, or 22.7%, to $31.8 million for the three months ended March 31, 2020 as compared to the same period in the prior year. The increase in gross profit was primarily driven by higher net sales.

Our gross profit margin of 45.4% for the three months ended March 31, 2020 decreased 190 basis points compared to the same period in the prior year, due to increased processing cost of 100 basis points, increased labor and overhead cost of 100 basis points due to 7 day production ramp up, plant start-up cost of 60 basis points and 30 basis points related to COVID-19 related cost, partially offset by increase in sales price and shifting selling mix of 100 basis points.

Adjusted Gross Profit was $34.7 million and $27.6 million in the three months ended March 31, 2020 and 2019 respectively. Adjusted Gross Profit Margin was 49.5% and 50.4% in the three months ended March 31, 2020 and 2019, respectively. Adjusted Gross Profit excludes $1.7 million of depreciation expense and $0.5 million of plant start-up expense and $0.4 million of share-based compensation expense and $0.2 million in COVID-19 expenses in the three months ended March 31, 2020 and excludes $1.6 million of depreciation expense and $0.1 million of share-based compensation expense in the three months ended March 31, 2019. See “—Non-GAAP Financial Measures” for how we define Adjusted Gross Profit and a reconciliation of Adjusted Gross Profit to Gross Profit, the closest comparable U.S. GAAP measure.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased $5.4 million, or 18.6%, to $34.7 million for the three months ended March 31, 2020 as compared to the same period in the prior year. Key components of the dollar increase include higher media expense of $1.7 million, higher incremental operating costs of $1.3 million, higher variable cost due to volume of $1.2 million and depreciation and options expense of $1.2 million. The increased operating expenses were primarily due to new hires, and increased employee incentive and benefit costs. As a percentage of net sales, selling, general and administrative expenses decreased to 49.5% for the three months ended March 31, 2020 from 53.4% for the three months ended March 31, 2019.

Adjusted SG&A decreased as a percentage of net sales to 41.3% in the three months ended March 31, 2020 as compared to 45.4% of net sales in the three months ended March 31, 2019. The decrease of 410 basis points in Adjusted SG&A is a result of 250 basis point gain in SG&A leverage, and 160 basis points leverage gain in media. Since the start of the Company’s Feed The Growth Initiative, the Company has gained approximately 660 basis points of leverage on

21

Adjusted SG&A. Adjusted SG&A excludes $2.7 million of depreciation expense, $1.7 million of non-cash share-based compensation expense, $1.0 million of launch expense, $0.3 million in enterprise resource planning expense and $0.1 million of equity offering expense in the three months ended March 31, 2020 while excluding $2.1 million of depreciation and amortization expense, $1.1 million for share-based compensation expense, and $1.1 million of launch expense in the three months ended March 31, 2019. See “—Non-GAAP Financial Measures” for how we define Adjusted SG&A and a reconciliation of Adjusted SG&A to SG&A, the closest comparable U.S. GAAP measure.

Loss from Operations

Loss from Operations decreased $0.4 million to $2.9 million for the three months ended March 31, 2020 as compared to the same period in the prior year as a result of the factors discussed above.

Interest Expense

Interest expense relating primarily to our credit facilities was $0.7 million for the three months ended March 31, 2020, of which $0.6 million was related to the recognition of debt issuance fees with the repayment of the Draw Term Loan, while interest expense was $0.1 million in the three months ended March 31, 2019.

Other Income/(Expenses), net

Other income (expenses), net increased less than $0.1 million for the three months ended March 31, 2020 compared to the same period in the prior year.

Net Loss

Net loss increased $0.2 million to $3.6 million for the three months ended March 31, 2020 as compared to loss of $3.4 million for the same period in the prior year as a result of the factors discussed above.

Non-GAAP Financial Measures

Freshpet uses the following non-GAAP financial measures in its financial communications. These non-GAAP financial measures should be considered as supplements to the GAAP reported measures, should not be considered replacements for, or superior to, the GAAP measures and may not be comparable to similarly named measures used by other companies.

•Adjusted Gross Profit

•Adjusted Gross Profit as a percentage of net sales (Adjusted Gross Margin)

•Adjusted SG&A expenses

•Adjusted SG&A expenses as a percentage of net sales

•EBITDA

•Adjusted EBITDA

•Adjusted EBITDA as a percentage of net sales

Such financial measures are not financial measures prepared in accordance with U.S. GAAP. We define Adjusted Gross Profit as Gross Profit before non-cash depreciation expense, plant start-up expense, COVID-19 expenses and non-cash share-based compensation. We define Adjusted SG&A as SG&A expenses before depreciation and amortization expense, non-cash share-based compensation, launch expense, loss on disposal of equipment, fees related to equity offerings, and fees associated with due diligence of new enterprise resource planning (“ERP”) software. EBITDA represents net loss plus interest expense, income tax expense, and depreciation and amortization. Adjusted EBITDA represents EBITDA plus loss on disposal of equipment, non-cash share-based compensation, launch expenses, plant start-up expense, fees related to equity offerings, COVID-19 expenses and fees associated with due diligence of new ERP software. We have changed our method for calculating Adjusted Gross Profit and Adjusted EBITDA in light of certain non-recurring expenses related to the COVID-19 pandemic.

22

We believe that each of these non-GAAP financial measures provide additional metrics to evaluate our operations and, when considered with both our U.S. GAAP results and the reconciliation to the closest comparable U.S. GAAP measures, provide a more complete understanding of our business than could be obtained absent this disclosure. We use the non-GAAP financial measures, together with U.S. GAAP financial measures, such as net sales, gross profit margins and cash flow from operations, to assess our historical and prospective operating performance, to provide meaningful comparisons of operating performance across periods, to enhance our understanding of our operating performance and to compare our performance to that of our peers and competitors.

Adjusted EBITDA is also an important component of internal budgeting and setting management compensation.

The non-GAAP financial measures are presented here because we believe they are useful to investors in assessing the operating performance of our business without the effect of non-cash items, and other items as detailed below. The non-GAAP financial measures should not be considered in isolation or as alternatives to net income (loss), income (loss) from operations or any other measure of financial performance calculated and prescribed in accordance with U.S. GAAP. Neither EBITDA nor Adjusted EBITDA should be considered a measure of discretionary cash available to us to invest in the growth of our business. Our non-GAAP financial measures may not be comparable to similarly titled measures in other organizations because other organizations may not calculate non-GAAP financial measures in the same manner as we do.

Our presentation of the non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by the expenses that are excluded from that term or by unusual or non-recurring items. We recognize that the non-GAAP financial measures have limitations as analytical financial measures. For example, the non-GAAP financial measures do not reflect:

• our capital expenditures or future requirements for capital expenditures;

• the interest expense, or the cash requirements necessary to service interest expense or principal payments, associated with indebtedness;

• depreciation and amortization, which are non-cash charges, although the assets being depreciated and amortized will likely have to be replaced in the future, nor any cash requirements for such replacements; and

• changes in or cash requirements for our working capital needs.

Additionally, Adjusted EBITDA excludes (i) non-cash share-based compensation expense, which is and will remain a key element of our overall long-term incentive compensation package, and (ii) certain costs essential to our sales growth and strategy, including an allowance for marketing expenses for each new store added to our network and non-capitalizable freight costs associated with Freshpet Fridge replacements. Adjusted EBITDA also excludes certain cash charges resulting from matters we consider not to be indicative of our ongoing operations. Other companies in our industry may calculate the non-GAAP financial measures differently than we do, limiting their usefulness as comparative measures.

The following table provides a reconciliation of EBITDA and Adjusted EBITDA to net loss, the most directly comparable financial measure presented in accordance with U.S. GAAP:

23

	Three Months Ended
	March 31,
	2020			2019
	(Dollars in thousands)
Net loss	$	(3,590	)	$	(3,422	)
Depreciation and amortization		4,453			3,720
Interest expense		704			103
Income tax expense		22			19
EBITDA	$	1,589		$	420
Loss on disposal of equipment		2			8
Non-cash share-based compensation		2,178			1,200
Launch expense (a)		957			1,123
Plant start-up expenses (b)		467			—
Equity offering expenses (c)		58			34
Enterprise Resource Planning software(d)		273			—
COVID-19 expense (e)		217			—
Adjusted EBITDA	$	5,741		$	2,785
Adjusted EBITDA as a % of Net Sales		8.2	%		5.1	%

(a) Represents new store marketing allowance of $1,000 for each store added to our distribution network, as well as the non-capitalized freight costs associated with Freshpet Fridge replacements. The expense enhances the overall marketing spend to support our growing distribution network.

(b) Represents additional operating costs incurred in connection with the start-up of our new manufacturing lines as part of the Freshpet Kitchens expansion projects.

(c) Represents fees associated with public offerings of our common stock.

(d) Represents fees associated with due diligence of new Enterprise Resource Planning software.

(e) Represents COVID-19 including (i) costs incurred to protect the health and safety of our employees during the COVID-19 pandemic, (ii) temporary increased compensation expense to ensure continued operations during the pandemic, and (iii) costs related to mitigate potential supply chain disruptions during the pandemic.

The following table provides a reconciliation of Adjusted Gross Profit to Gross Profit, the most directly comparable financial measure presented in accordance with U.S. GAAP:

	Three Months Ended
	March 31,
	2020			2019
	(Dollars in thousands)
Gross Profit	$	31,790		$	25,915
Depreciation expense (a)		1,744			1,566
Plant start-up expense (b)		467			—
Non-cash share-based compensation (c)		449			148
COVID-19 expense (d)		217			—
Adjusted Gross Profit	$	34,667		$	27,629
Adjusted Gross Profit as a % of Net Sales		49.5	%		50.4	%

(a) Represents depreciation and amortization expense included in cost of goods sold.

(b) Represents additional operating costs incurred in connection with the start-up of our new manufacturing lines as part of the Freshpet Kitchens expansion projects.

(c) Represents non-cash share-based compensation expense included in cost of goods sold.

(d) Represents COVID-19 including (i) costs incurred to protect the health and safety of our employees during the COVID-19 pandemic, (ii) temporary increased compensation expense to ensure continued operations during the pandemic, and (iii) costs related to mitigate potential supply chain disruptions during the pandemic.

24

The following table provides a reconciliation of Adjusted SG&A Expenses to SG&A Expenses, the most directly comparable financial measure presented in accordance with U.S. GAAP:

	Three Months Ended
	March 31,
	2020			2019
	(Dollars in thousands)
SG&A expenses	$	34,676		$	29,232
Depreciation and amortization expense (a)		2,709			2,154
Non-cash share-based compensation (b)		1,729			1,052
Launch expense (c)		957			1,123
Loss on disposal of equipment		2			—
Equity offering expenses (d)		58			34
Enterprise Resource Planning software (e)		273			—
Adjusted SG&A Expenses	$	28,948		$	24,869
Adjusted SG&A Expenses as a % of Net Sales		41.3	%		45.4	%

(a) Represents non-cash depreciation expense included in SG&A.

(b) Represents non-cash share-based compensation expense included in SG&A.

(c) Represents new store marketing allowance of $1,000 for each store added to our distribution network, as well as the non-capitalized freight costs associated with Freshpet Fridge replacements. The expense enhances the overall marketing spend to support our growing distribution network.

(d) Represents fees associated with public offerings of our common stock.

(e) Represents fees associated with due diligence of new Enterprise Resource Planning software.

Liquidity and Capital Resources

Developing our business will require significant capital in the future. To meet our capital needs, we expect to rely on our current and future cash flow from operations and our current and future available borrowing capacity. Our ability to obtain additional funding will be subject to various factors, including general market conditions, our operating performance, the market’s perception of our growth potential, lender sentiment and our ability to incur additional debt in compliance with other contractual restrictions, such as financial covenants under our debt agreements.

Additionally, our ability to make payments on, and to refinance, any indebtedness under our credit facilities and to fund any necessary expenditures for our growth will depend on our ability to generate cash in the future. If our business does not achieve the levels of profitability or generate the amount of cash that we anticipate or if we expand faster than anticipated, we may need to seek additional debt or equity financing to operate and expand our business. Future third-party financing may not be available on favorable terms or at all.

Our primary cash needs are for ingredients, packaging and operating expenses, marketing expenses and capital expenditures to procure Freshpet Fridges and expand and improve our manufacturing plant to support our net sales growth.

Over the next three years we also expect to invest over $300 million in capital expenditures to expand our plant capacity and increase distribution. We believe that our cash and cash equivalents, short-term investments, expected cash flow from operations and planned borrowing capacity are adequate to fund debt service requirements, operating lease obligations, capital expenditures and working capital obligations for the foreseeable future. From time to time, we may seek to raise additional capital by accessing the debt and/or equity markets to fund capital expenditures or otherwise However, our ability to continue to meet our capital resource requirements and obligations will depend on, among other things, our ability to achieve anticipated levels of revenue and cash flow from operations, our ability to manage costs and working capital successfully and our ability to access the debt and equity markets. Additionally, our cash flow generation ability is subject to general economic, financial, competitive, legislative and regulatory factors and other factors that are beyond our control. We cannot assure you that our business will generate cash flow from operations in an amount sufficient to enable us to fund our liquidity needs. Further, our capital requirements may vary materially from those currently planned if, for example, our revenues do not reach expected levels, or we have to incur unforeseen capital expenditures and make investments to maintain our competitive position. If this is the case, we may seek alternative

25

financing, such as selling additional debt or equity securities, and we cannot assure you that we will be able to do so on favorable terms, if at all. Moreover, if we issue new debt securities, the debt holders would have rights senior to common stockholders to make claims on our assets, and the terms of any debt could restrict our operations, including our ability to pay dividends on our common stock. If we issue additional equity or convertible debt securities, existing stockholders may experience dilution, and such new securities could have rights senior to those of our common stock. These factors may make the timing, amount, terms and conditions of additional financings unattractive. Our inability to raise capital could impede our growth or otherwise require us to forego growth opportunities and could materially adversely affect our business, financial condition and results of operations.

The following table sets forth, for the periods indicated, our working capital:

	March 31,			December 31,
	2020			2019
	(Dollars in thousands)
Cash and cash equivalents		149,486			9,472
Short-term investments		20,000			—
Accounts receivable, net of allowance for doubtful accounts		20,295			18,581
Inventories, net		16,005			12,542
Prepaid expenses		2,998			3,276
Other current assets		10,721			10,453
Accounts payable		(20,421	)		(18,668	)
Accrued expenses		(20,440	)		(22,133	)
Current operating lease liabilities		(1,241	)		(1,185	)
Total Working Capital	$	177,403		$	12,338

Working capital consists of current assets net of current liabilities. Working capital increased $165.1 million to $177.4 million at March 31, 2020 compared with working capital of $12.3 million at December 31, 2019. The increase was mainly a result of the equity raise and an increase in accounts receivable and inventories, offset by an increase in accounts payable. The increase in accounts receivable and inventories is mainly due to the growing business. The increase in accounts payable was mainly due to capex spend of $8.7 million that was within accounts payable as of March 31, 2020. The increase in accounts receivable and inventory is a result of the growth the Company has experienced during the year.

We normally carry three to four weeks of finished goods inventory. The average duration of our accounts receivable is approximately three to four weeks.

As of March 31, 2020, our capital resources consisted primarily of $149.5 million of cash on hand, $20.0 million in short-term investments and $35.0 million available under our credit facilities, of which $2.0 million is reserved for two Letters of Credit.

We expect to fund our ongoing operations and obligations with cash and cash equivalents, cash flow from operations and available funds under our credit facilities.

The following table sets forth, for the periods indicated, our beginning balance of cash, net cash flows provided by (or used in) operating, investing and financing activities and our ending balance of cash.

	Three Months Ended March 31,
	2020			2019
	(Dollars in thousands)
Cash at the beginning of period	$	9,472		$	7,554
Net cash used in operating activities		(2,501	)		(4,457	)
Net cash used in investing activities		(54,238	)		(10,454	)
Net cash provided by financing activities		196,753			11,118
Cash at the end of period	$	149,486		$	3,761

26

Net Cash Used in Operating Activities

Cash used in operating activities consists primarily of net loss adjusted for certain non-cash items (i.e. provision for loss on receivables, loss on disposal of equipment, change in reserve for inventory obsolescence, depreciation and amortization, amortization of deferred financing costs and loan discount, and share-based compensation).

For the three months ended March 31, 2020, net cash used in operating activities of $2.5 million was primarily attributed to:

• $6.1 million increase in working capital mainly due to a $5.1 million change in assets and a $1.0 million change in liabilities.

• $0.3 million increase in other lease liabilities.

This was partially offset by:

• $3.9 million of net income, adjusted for reconciling non-cash items, which excludes $7.5 million primarily related to $2.2 million of share-based compensation and $4.5 million of depreciation and amortization.

For the three months ended March 31, 2019, net cash used in operating activities of $4.5 million was primarily attributed to:

• $5.8 million increase in working capital mainly due to $7.5 million increase in assets, a result of an increase in inventory, accounts receivable, prepaid expenses and other current assets, offset by an increase in liabilities of $1.5 million, mainly a result of an increase in accounts payable and timing of payments related to compensation.

• $0.2 million increase in other lease liabilities.

This was partially offset by:

• $1.5 million of net income, adjusted for reconciling non-cash items, which excludes $5.0 million primarily related to $1.2 million of share-based compensation and $3.7 million of depreciation and amortization.

Net Cash Used in Investing Activities

Net cash used in investing activities of $54.2 million for the three months ended March 31, 2020, was primarily related to:

• $28.1 million in capital expenditures for Freshpet Kitchens, of which $25.6 million relates to the Freshpet Kitchens and other expansion projects and $2.5 million relates to recurring capital expenditures.

• $6.1 million in capital expenditures relating to investment in fridges and other capital spend.

• $20.0 million purchase of short term investments.

Net cash used in investing activities of $10.5 million for the three months ended March 31, 2019, was primarily related to:

• $6.0 million in capital expenditures for Freshpet Kitchens, of which $4.9 million relates to the Freshpet Kitchens expansion and $1.1 million relates to recurring capital expenditures.

• $4.5 million in capital expenditures relates to investment in fridges and other capital spend.

Net Cash Provided by Financing Activities

Net cash provided by financing activities was $196.8 million for the three months ended March 31, 2020, attributable to:

• $252.1 million of proceeds from common shares issued in primary offering, net of issuance cost.

• $20.9 million of proceeds from borrowings under our credit facilities.

• $0.4 million cash proceeds from the exercise of stock options.

27

This was partially offset by:

• $76.0 million repayment of borrowings under credit facilities.

• $0.6 million for tax withholdings related to net share settlements of restricted stock units.

Net cash provided by financing activities was $11.1 million for the three months ended March 31, 2019, attributable to:

• $10.0 million of proceeds from borrowings under our credit facilities.

• $1.8 million cash proceeds from the exercise of stock options.

This was partially offset by:

• $0.7 million for tax withholdings related to net share settlements of restricted stock units.

Indebtedness

For a discussion of our material indebtedness, see Notes 5 and 11 to our consolidated financial statements included in this report.

Contractual Obligations

There were no material changes to our commitments under contractual obligations, as disclosed in our latest Annual Report Form 10-K.

Off Balance Sheet Arrangements

We have no off balance sheet arrangements or any holdings in variable interest entities.

Critical Accounting Policies and Significant Estimates

Our management’s discussion and analysis of financial condition and results of operations is based on our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States, or GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the revenue and expenses incurred during the reported periods. On an ongoing basis, we evaluate our estimates and judgments, including those related to accrued expenses and share-based compensation. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not apparent from other sources. Changes in estimates are reflected in reported results for the period in which they become known. Actual results may differ from these estimates under different assumptions or conditions.

There have been no material changes to our critical accounting policies and estimates as compared to the critical accounting policies and estimates described in our latest Annual Report Form 10-K.

Recent Accounting Pronouncements

Recently Adopted Standards:

See Note 1 of our consolidated financial statements for additional information.

Standards Effective in Future Years:

28

We consider the applicability and impact of all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB). ASUs not listed herein were assessed and determined to be either not applicable or are expected to have minimal impact to our consolidated financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risks

Interest Rate Risk

We are sometimes exposed to market risks from changes in interest rates on debt and changes in commodity prices. Our exposure to interest rate fluctuations is limited to our outstanding indebtedness under our credit facilities, which bears interest at variable rates. During the quarter ended March 31, 2020, we borrowed $20.9 million from our credit facilities,  all of which was repaid as of March 31, 2020.

Commodity Price Risk

We purchase certain products that are affected by commodity prices and are, therefore, subject to price volatility caused by weather, market conditions and other factors which are not considered predictable or within our control. In many cases, we believe we will be able to address material commodity cost increases by either increasing prices or reducing operating expenses. However, increases in commodity prices, without adjustments to pricing or reduction to operating expenses, could increase our operating costs as a percentage of our net sales.

Foreign Exchange Rates

Fluctuations in the currencies of countries where the Company operates outside the U.S. may have a significant impact on financial results. The Company is exposed to movements in the British pound sterling and Euro. The Statements of Financial Position of non-U.S. business units are translated into U.S. dollars using period-end exchange rates for assets and liabilities and weighted-average exchange rates for revenues and expenses. The percentage of consolidated revenue for both the three months ended March 31, 2020 recognized in Europe was approximately 1%.

The Company may, from time to time, enter into forward exchange contracts to reduce the Company’s exposure to foreign currency fluctuations of certain assets and liabilities denominated in foreign currencies. Historically, the foreign currency forward contracts have not been designated as hedges and, accordingly, any changes in their fair value are recognized on the Consolidated Statements of Operations and Comprehensive Income (Loss) in Other expenses, net, and carried at their fair value in the Consolidated Balance Sheet with gains reported in prepaid expenses and other current assets and losses reported in accrued expenses. As of March 31, 2020, there were no forward contracts outstanding.

29

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of such date our disclosure controls and procedures were effective.

Changes in Internal Control

There were no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the period covered by this Quarterly Report on Form 10-Q that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

Our management, including our Chief Executive Officer and Chief Financial Officer, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

30

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

A securities lawsuit, Curran v. Freshpet, Inc. et al, Docket No. 2:16-cv-02263, was instituted April 21, 2016 in the United States District Court for the District of New Jersey against us and certain of our current and former executive officers and directors on behalf of certain purchasers of our common stock. We were served with a copy of the complaint in June 2016. The plaintiffs sought to recover damages for investors under the federal securities laws. The parties filed briefing on class certification and engaged in fact and expert discovery. The parties then entered into mediation and settlement discussions, after which the parties entered into stipulation of settlement to amicably resolve the dispute. All parties to the agreement believed that it was in their respective best interests to settle the dispute in order to avoid the risk, uncertainty, and costs associated with litigation. Under the settlement, Freshpet and its related defendants agreed to settle the litigation for $10.1 million, subject to the approval of the District Court. The settlement funds due were paid by the Company’s insurers, and the District Court approved the Final Judgment and Order of Dismissal with Prejudice on March 11, 2020. There was no appeal taken within 30 days from the entry of the Final Judgment. The Final Judgment became effective April 10, 2020.

A shareholder derivative lawsuit, Meldon v. Freshpet, Inc. et al, Docket No. 2:18-cv-10166, was instituted June 5, 2018 in the United States District Court for the District of New Jersey against us and certain of our current and former executive officers and directors on behalf of certain holders of our common stock. We were served with a copy of the complaint in June 2018. The plaintiffs seek to recover damages for investors based on state law claims (alleged breaches of fiduciary duty, waste, and unjust enrichment) in connection with the alleged violations of federal securities laws alleged in the Curran action. On April 3, 2019, the Court granted a stay of the Meldon case pending (i) the close of expert discovery in the Curran action or (ii) the dismissal with prejudice of the Curran action. The parties then entered into settlement discussions, after which the parties reached an agreement in principle to settle the case based on the Company’s commitment to continue certain governance practices. The parties also reached agreement on attorneys’ fees. The settlement is subject to Court approval. All parties believe that the agreement in principle to settle the dispute is in their respective best interests in order to avoid the risk, uncertainty, and costs associated with litigation. The parties are in the process of finalizing the settlement documents for submission to the District Court. As of March 31, 2020, the Company accrued for an estimated probable loss of $0.2 million, which represents the proposed settlement and accrued legal fees. The Company concluded that the insurance recovery is probable and recorded a gain contingency of $0.2 million within other current assets.

In addition, we are currently involved in various claims and legal actions that arise in the ordinary course of our business, including claims resulting from employment related matters. None of these claims or proceedings, most of which are covered by insurance, are expected to have a material adverse effect on our business, financial condition, results of operations or cash flows. However, a significant increase in the number of these claims or an increase in amounts owing under successful claims could materially and adversely affect our business, financial condition, results of operations or cash flows.

Item 1A. Risk Factors

The information set forth below supplements, and should be read in conjunction with, the “Risk Factors” section in the Company’s Annual Report on Form 10-K, as amended, for the year ended December 31, 2019.

The COVID-19 outbreak has had a material impact on the U.S. and global economies and could have a material adverse impact on our employees, suppliers, customers and end consumers, which could adversely and materially impact our business, financial condition and results of operations.

In December 2019, a novel coronavirus disease (“COVID-19”) was reported and in January 2020, the World Health Organization (“WHO”) declared it a Public Health Emergency of International Concern. In late February 2020, the WHO raised its assessment of the COVID-19 threat from high to very high at a global level due to the continued increase in the number of cases and affected countries, and in March 2020, the WHO characterized COVID-19 as a pandemic.

31

COVID-19 may affect demand for our products due to quarantines, government restrictions on movements, or other societal changes. Governmental or societal impositions of restrictions on public gatherings, especially if prolonged in nature, may have adverse effects on in-person traffic to retail stores and, in turn, our business. Even the perceived risk of infection or health risk may adversely affect traffic to retail customers and, in turn, our business, liquidity, financial condition and results of operations. Further, if any circumstances related to the pandemic cause consumers to change how they feel about the presence of pets in their households, that could have a material impact on demand. 

The spread of pandemics, epidemics or disease outbreaks such as COVID-19 may also disrupt our third party business partners’ ability to meet their obligations to us, which may negatively affect our operations. These third parties include those who supply our ingredients, packaging, and other necessary operating materials, contract manufacturers, distributors, and logistics and transportation services providers. As a result of the current COVID-19 outbreak, transport restrictions related to quarantines or travel bans have been put in place and global supply may become constrained, each of which may cause the price of certain ingredients and raw materials used in our products to increase and/or we may experience disruptions to our operations.

Workforce limitations and travel restrictions resulting from pandemics, epidemics or disease outbreaks such as COVID-19 and related government actions may affect many aspects of our business. If a significant percentage of our workforce is unable to work, including because of illness or travel or government restrictions in connection with pandemics or disease outbreaks, our operations, including manufacturing at our Freshpet Kitchens may be negatively affected. Additionally, the Company has incurred, and may continue to incur additional costs related to initiatives that increase workplace safety and attempt to minimize potential manufacturing shutdowns.  

Our results of operations depend on, among other things, our ability to maintain and increase sales volume with our existing retail customers and consumers, and to attract new customers and consumers. Our ability to implement our advertising, increase our distribution, and innovate new products, that are designed to increase and maintain sales volumes may be negatively affected as a result of decreased retailer traffic, modifications to retailer shelf reset timing or other activities during the COVID-19 outbreak. Retailers may also alter their normal inventory receiving and product restocking practices during pandemics, epidemics or disease outbreaks such as COVID-19, which may negatively impact our business.

Adverse and uncertain economic conditions, such as decreases in per capita income and level of disposable income, increased unemployment or a decline in consumer confidence as a result of the COVID-19 outbreak or similar situations, could have an adverse effect on distributor, retailer and consumer demand for our products. Consumers may shift purchases to lower-priced or other perceived value offerings during economic downturns. Prolonged unfavorable economic conditions, including as a result of COVID-19 or similar outbreaks, and any resulting recession or slowed economic growth, may have an adverse effect on our sales and profitability.

Our efforts to manage and mitigate these factors may be unsuccessful, and the effectiveness of these efforts depends on factors beyond our control, including the duration and severity of any pandemic, epidemic or disease outbreak, as well as third party actions taken to contain its spread and mitigate public health effects.

32

Item 6. Exhibits

Exhibit No.	Description
10.1	First Amended and Restated Loan and Security Agreement Amendment, dated April 17, 2020, by and among the Company and City National Bank, a national banking association, as the arranger and administrative agent, and the lenders thereto (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on April 20, 2020).
31.1*	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*	Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
EX-101.INS*	Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the inline XBRL document.
EX-101.SCH*	Inline XBRL Taxonomy Extension Schema Document
EX-101.CAL*	Inline XBRL Taxonomy Extension Calculation Linkbase Document
EX-101.LAB*	Inline XBRL Taxonomy Extension Label Linkbase Document
EX-101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document
EX-101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase Document
EX-104	Inline XBRL Formatted Cover Page.

*  Filed herewith.

33

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 5, 2020	FRESHPET, INC.
	/s/ William B. Cyr William B. Cyr Chief Executive Officer (Principal Executive Officer)
	/s/ Richard Kassar
	Richard Kassar Chief Financial Officer
	(Principal Financial and Accounting Officer)

34

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, William B. Cyr, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Freshpet, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the

audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 5, 2020

/s/ William B. Cyr                                

William B. Cyr

Chief Executive Officer

2

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Richard Kassar, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Freshpet, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the

audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 5, 2020

/s/ Richard Kassar                                

Richard Kassar

Chief Financial Officer

2

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. § 1350,

AS ADOPTED PURSUANT TO § 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the filing of the Quarterly Report on Form 10-Q of Freshpet, Inc., a Delaware corporation (the “Company”), for the quarter ended March 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to such officer’s knowledge:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

Date: May 5, 2020

/s/ William B. Cyr_______________

William B. Cyr

Chief Executive Officer

/s/ Richard Kassar                              

Richard Kassar

Chief Financial Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.

XML

Leases - Maturities of Lease Liabilities Under Noncancelable Operating Leases (Details)	Mar. 31, 2020 USD ($)
Leases [Abstract]
2020	$ 1,319,802
2021	1,768,626
2022	1,763,787
2023	1,802,007
2024	1,511,214
2024 and beyond	2,786,004
Total lease payments	10,951,440
Less: Imputed interest	(1,641,112)
Present value of lease liabilities	$ 9,310,328

XML

Accrued Expenses - Summary of Accrued Expenses (Details) - USD ($)		Mar. 31, 2020	Dec. 31, 2019
Payables And Accruals [Abstract]
Legal Contingency		$ 10,310,000	$ 10,100,000
Accrued Compensation and Employee Related Costs		4,033,898	6,390,692
Accrued Chiller Cost		1,548,752	1,576,214
Accrued Customer Consideration		735,172	635,399
Accrued Freight		726,381	702,673
Accrued Production Expenses		1,801,527	413,550
Accrued Marketing		595,376	1,187,885
Other Accrued Expenses		689,362	1,126,515
Accrued expenses	[1]	$ 20,440,468	$ 22,132,928

[1] See Note 10 for additional information.

XML

Equity Incentive Plans - Summary of Activity Related to Outstanding Stock Options (Details)	3 Months Ended
	Mar. 31, 2020 $ / shares shares
Service Period Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares, Outstanding Beginning Balance | shares	1,359,990
Shares, Granted | shares	15,000
Shares, Exercised | shares	(44,156)
Shares, Forfeited | shares	(357)
Shares, Outstanding Ending Balance | shares	1,330,477
Weighted Average Exercise Price, Outstanding Beginning Balance | $ / shares	$ 11.50
Weighted Average Exercise Price, Granted | $ / shares	60.10
Weighted Average Exercise Price, Exercised | $ / shares	9.11
Weighted Average Exercise Price, Forfeited | $ / shares	11.00
Weighted Average Exercise Price, Outstanding Ending Balance | $ / shares	$ 12.13
Performance-Vested Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares, Outstanding Beginning Balance | shares	1,372,819
Shares, Outstanding Ending Balance | shares	1,372,819
Weighted Average Exercise Price, Outstanding Beginning Balance | $ / shares	$ 18.31
Weighted Average Exercise Price, Outstanding Ending Balance | $ / shares	$ 18.31
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares, Outstanding Beginning Balance | shares	240,229
Shares, Granted | shares	5,280
Shares, Issued upon vesting | shares	(32,727)
Shares, Forfeited | shares	(604)
Shares, Outstanding Ending Balance | shares	212,178
Weighted-Average Grant-Date Fair Value Per Unit, Outstanding Beginning Balance | $ / shares	$ 29.07
Weighted-Average Grant-Date Fair Value Per Unit, Granted | $ / shares	62.88
Weighted-Average Grant-Date Fair Value Per Unit, Issued Upon Vesting | $ / shares	17.56
Weighted-Average Grant-Date Fair Value Per Unit, Forfeited | $ / shares	32.83
Weighted-Average Grant-Date Fair Value Per Unit, Outstanding Ending Balance | $ / shares	$ 31.68

XML

Leases

3 Months Ended

Mar. 31, 2020

Leases [Abstract]

Leases

Note 6– Leases:

We have various noncancellable lease agreements for office and warehouse space, as well as office equipment, with original remaining lease terms of two years to nine years, some of which include an option to extend the lease term for up to five years. Because the Company is not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term, and associated potential option payments are excluded from lease payments. The Company’s leases generally do not include termination options for either party to the lease or restrictive financial or other covenants.

Weighted-average remaining lease term (in years) and discount rate related to operating leases were as follows:

Weighted-average remaining lease term	5.99
Weighted-average discount rate	6.14	%

As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the date of adoption to determine the present value of lease payments.

Maturities of lease liabilities under noncancellable operating leases as of March 31, 2020 were as follows:

	March 31, 2020
2020 (a)		1,319,802
2021		1,768,626
2022		1,763,787
2023		1,802,007
2024		1,511,214
2024 and beyond		2,786,004
Total lease payments		10,951,440
Less: Imputed interest		(1,641,112	)
Present value of lease liabilities	$	9,310,328

(a) Excluding the three months ended March 31, 2020.

A summary of rent expense for the three months ended March 31, 2020 and 2019 was as follows:

	For the Three Months Ended
	March 31,
	2020		2019
Operating lease cost	$	452,155	$	256,882

Supplemental cash flow information and non-cash activity relating to operating leases are as follows:

	For the Three Months Ended March 31,
	2020		2019
Operating cash flow information:
Cash paid for amounts included in the measurement of lease liabilities	$	283,982	$	246,735

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2020

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 10 – Commitments and Contingencies:

A securities lawsuit, Curran v. Freshpet, Inc. et al, Docket No. 2:16-cv-02263, was instituted on April 21, 2016 in the United States District Court for the District of New Jersey against the Company and certain of the Company’s current and former executive officers and directors on behalf of certain purchasers of our common stock. The plaintiffs sought to recover damages for investors under the federal securities laws.  On October 3, 2019, the parties filed with the District Court a motion for preliminary approval of settlement that attached the parties’ stipulation of settlement and a proposed order. The settlement funds due, held in escrow, were paid by the Company’s insurers, and the District Court approved the Final Judgment and Order of Dismissal with Prejudice on March 11, 2020 with a 30 day option to appeal.  As of March 31, 2020, the Company accrued for an estimated probable loss of $10.1 million, which represents the settlement amount and accrued legal fees. The Company concluded that the insurance recovery is probable and recorded a gain contingency of $10.1 within other current assets. There was no appeal taken within 30 days from the entry of the Judgment. The Judgment was Effective April 10, 2020.

A shareholder derivative lawsuit, Meldon v. Freshpet, Inc. et al, Docket No. 2:18-cv-10166, was instituted June 5, 2018 in the United States District Court for the District of New Jersey against us and certain of our current and former executive officers and directors on behalf of certain holders of our common stock. We were served with a copy of the complaint in June 2018. The plaintiffs seek to recover damages for investors based on state law claims (alleged breaches of fiduciary duty, waste, and unjust enrichment) in connection with the alleged violations of federal securities laws alleged in the Curran action. On April 3, 2019, the Court granted a stay of the Meldon case pending (i) the close of expert discovery in the Curran action or (ii) the dismissal with prejudice of the Curran action. The parties then entered into settlement discussions, after which the parties reached an agreement in principle to settle the case based on the Company’s commitment to continue certain governance practices. The parties also reached agreement on attorneys’ fees. The settlement is subject to court approval. All parties believe that the agreement in principle to settle the dispute is in their respective best interests in order to avoid the risk, uncertainty, and costs associated with litigation. The parties are in the process of finalizing the settlement documents for submission to the District Court. As of March 31,2020, the Company accrued for an estimated probable loss of $0.2 million, which represents the proposed settlement and accrued legal fees. The Company concluded that the insurance recovery is probable and recorded a gain contingency of $0.2 million within other current assets.

XML

Inventories - Summary of Inventories (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Raw Materials and Work in Process	$ 4,184,814	$ 4,453,498
Packaging Components Material	1,869,166	1,419,155
Finished Goods	10,092,896	6,842,359
Inventory gross	16,146,876	12,715,012
Reserve for Obsolete Inventory	(141,506)	(172,743)
Inventory net	$ 16,005,370	$ 12,542,269

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2020

Inventory Disclosure [Abstract]

Summary of Inventories

	March 31,			December 31,
	2020			2019
Raw Materials and Work in Process	$	4,184,814		$	4,453,498
Packaging Components Material		1,869,166			1,419,155
Finished Goods		10,092,896			6,842,359
		16,146,876			12,715,012
Reserve for Obsolete Inventory		(141,506	)		(172,743	)
	$	16,005,370		$	12,542,269

XML

Equity Incentive Plans (Tables)

3 Months Ended

Mar. 31, 2020

Service Period Stock Options

Summary of Activity Related to Outstanding Stock Options

The following table includes activity related to outstanding service period stock options during the three months ended March 31, 2020.

Service Period Stock Options	Shares			Weighted Average Exercise Price
Outstanding at December 31, 2019		1,359,990		$	11.50
Granted		15,000			60.10
Exercised		(44,156	)		9.11
Forfeited		(357	)		11.00
Outstanding at March 31, 2020		1,330,477		$	12.13

Performance-Vested Stock Options

Summary of Activity Related to Outstanding Stock Options

The following table includes activity related to outstanding performance-vested stock options during the nine months ended March 31, 2020.

Performance Based Options	Shares		Weighted Average Exercise Price
Outstanding at December 31, 2019		1,372,819	$	18.31
Granted		—		—
Exercised		—		—
Forfeited		—		—
Outstanding at March 31, 2020		1,372,819	$	18.31

Restricted Stock Units

Summary of Activity Related to Outstanding Stock Options

The following table includes activity related to outstanding restricted stock units during the three months ended March 31, 2020.

Restricted Stock Units	Shares			Weighted-Average Grant-Date Fair Value Per Unit
Outstanding at December 31, 2019		240,229		$	29.07
Granted		5,280			62.88
Issued upon vesting		(32,727	)		17.56
Forfeited		(604	)		32.83
Outstanding at March 31, 2020		212,178		$	31.68

XML

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
NET SALES	$ 70,097,805	$ 54,792,202
COST OF GOODS SOLD	38,308,179	28,877,221
GROSS PROFIT	31,789,626	25,914,981
SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES	34,675,943	29,232,250
LOSS FROM OPERATIONS	(2,886,317)	(3,317,269)
OTHER INCOME/(EXPENSES):
Other Income/(Expenses), net	21,518	17,295
Interest Expense	(703,834)	(102,776)
Other Income/(Expenses), Total	(682,316)	(85,481)
LOSS BEFORE INCOME TAXES	(3,568,633)	(3,402,750)
INCOME TAX EXPENSE	21,600	19,250
LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	(3,590,233)	(3,422,000)
OTHER COMPREHENSIVE INCOME (LOSS):
Change in foreign currency translation	58,955	91,047
TOTAL OTHER COMPREHENSIVE INCOME	58,955	91,047
TOTAL COMPREHENSIVE LOSS	$ (3,531,278)	$ (3,330,953)
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS
-BASIC	$ (0.10)	$ (0.10)
-DILUTED	$ (0.10)	$ (0.10)
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING USED IN COMPUTING NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS
-BASIC	37,443,758	35,668,323
-DILUTED	37,443,758	35,668,323

XML

Inventories

3 Months Ended

Mar. 31, 2020

Inventory Disclosure [Abstract]

Inventories

Note 2 – Inventories:

	March 31,			December 31,
	2020			2019
Raw Materials and Work in Process	$	4,184,814		$	4,453,498
Packaging Components Material		1,869,166			1,419,155
Finished Goods		10,092,896			6,842,359
		16,146,876			12,715,012
Reserve for Obsolete Inventory		(141,506	)		(172,743	)
	$	16,005,370		$	12,542,269

XML

Net Loss Per Share Attributable to Common Shareholder - Schedule of Potentially Dilutive Securities (Details) - shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities	1,631,917	1,994,993
Service Period Stock Options
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities	1,355,853	1,686,048
Restricted Stock Units
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities	241,582	249,252
Performance Shares
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities	34,482	59,693

XML

Property, Plant and Equipment (Tables)

3 Months Ended

Mar. 31, 2020

Property Plant And Equipment [Abstract]

Summary of Property, Plant and Equipment, Net

	March 31,			December 31,
	2020			2019
Refrigeration Equipment	$	102,591,520		$	97,568,137
Machinery and Equipment		68,781,746			54,274,118
Building, Land, and Improvements		25,621,495			25,621,495
Furniture and Office Equipment		4,969,901			4,931,703
Leasehold Improvements		395,241			395,241
Automotive Equipment		309,137			309,137
Construction in Progress		73,702,188			58,587,375
		276,371,228			241,687,206
Less: Accumulated Depreciation		(80,763,454	)		(76,399,609	)
	$	195,607,774		$	165,287,597

XML

Net Loss Per Share Attributable to Common Shareholder (Tables)

3 Months Ended

Mar. 31, 2020

Earnings Per Share [Abstract]

Schedule of Potentially Dilutive Securities

The potentially dilutive securities are as follows:

	Three Months Ended
	March 31,
	2020		2019
Service Period Stock Options		1,355,853		1,686,048
Restricted Stock Units		241,582		249,252
Performance Stock Options		34,482		59,693
Total		1,631,917		1,994,993

XML

Property, Plant and Equipment - Summary of Property, Plant and Equipment, Net (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	$ 276,371,228	$ 241,687,206
Less: Accumulated Depreciation	(80,763,454)	(76,399,609)
Property, plant and equipment, net	195,607,774	165,287,597
Refrigeration Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	102,591,520	97,568,137
Machinery and Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	68,781,746	54,274,118
Building, Land, and Improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	25,621,495	25,621,495
Furniture and Office Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	4,969,901	4,931,703
Leasehold Improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	395,241	395,241
Automotive Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	309,137	309,137
Construction in Progress
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	$ 73,702,188	$ 58,587,375

XML

Property, Plant and Equipment

3 Months Ended

Mar. 31, 2020

Property Plant And Equipment [Abstract]

Property, Plant and Equipment

Note 3 – Property, Plant and Equipment:

	March 31,			December 31,
	2020			2019
Refrigeration Equipment	$	102,591,520		$	97,568,137
Machinery and Equipment		68,781,746			54,274,118
Building, Land, and Improvements		25,621,495			25,621,495
Furniture and Office Equipment		4,969,901			4,931,703
Leasehold Improvements		395,241			395,241
Automotive Equipment		309,137			309,137
Construction in Progress		73,702,188			58,587,375
		276,371,228			241,687,206
Less: Accumulated Depreciation		(80,763,454	)		(76,399,609	)
	$	195,607,774		$	165,287,597

Depreciation expense related to property, plant and equipment totaled $4,372,792 for the three months ended March 31, 2020, of which $1,743,657 was recorded to cost of goods sold for the three months ended March 31, 2020, with the remainder of depreciation and amortization expense recorded to selling, general and administrative expense. 

Depreciation expense related to property, plant and equipment totaled $3,643,492 for the three months ended March 31, 2019, of which $1,566,088 was recorded to cost of goods sold for the three months ended March 31, 2019, with the remainder of depreciation and amortization expense recorded to selling, general and administrative expense.

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	May 01, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Trading Symbol	FRPT
Entity Registrant Name	FRESHPET, INC.
Entity Central Index Key	0001611647
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Entity Common Stock, Shares Outstanding		40,266,181
Entity Shell Company	false
Entity File Number	001-36729
Entity Tax Identification Number	20-1884894
Entity Address, Address Line One	400 Plaza Drive
Entity Address, Address Line Two	1st Floor
Entity Address, City or Town	Secaucus
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07094
City Area Code	201
Local Phone Number	520-4000
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common Stock
Security Exchange Name	NASDAQ
Entity Incorporation, State or Country Code	DE
Document Quarterly Report	true
Document Transition Report	false

XML

CHANGES TO STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Total	Common Stock - Voting	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Treasury Stock
BALANCES at Dec. 31, 2018	$ 121,474,475	$ 35,556	$ 323,079,437	$ (201,352,682)	$ (31,610)	$ (256,226)
Shares, Outstanding at Dec. 31, 2018		35,556,595				14,169
Exercise of options to purchase common stock	1,791,668	$ 248	1,791,420
Exercise of options to purchase common stock, shares		248,195
Issuance of restricted stock units	(673,774)	$ 62	(673,836)
Issuance of restricted stock units, shares		61,532
Share-based compensation expense	1,260,126		1,260,126
Foreign Currency Translation	91,047				91,047
Net income (loss)	(3,422,000)			(3,422,000)
BALANCES at Mar. 31, 2019	120,521,542	$ 35,866	325,457,147	(204,774,682)	59,437	$ (256,226)
Shares, Outstanding at Mar. 31, 2019		35,866,322				14,169
BALANCES at Dec. 31, 2019	131,264,521	$ 36,162	334,299,172	(202,735,417)	(79,170)	$ (256,226)
Shares, Outstanding at Dec. 31, 2019		36,162,433				14,169
Exercise of options to purchase common stock	402,556	$ 44	402,512
Exercise of options to purchase common stock, shares		44,156
Issuance of restricted stock units	(644,599)	$ 65	(644,664)
Issuance of restricted stock units, shares		64,823
Share-based compensation expense	2,241,847		2,241,847
Shares issued in primary offering	252,062,254	$ 4,000	252,058,254
Shares issued in primary offering, shares		3,999,999
Foreign Currency Translation	58,955				58,955
Net income (loss)	(3,590,233)			(3,590,233)
BALANCES at Mar. 31, 2020	$ 381,795,301	$ 40,271	$ 588,357,121	$ (206,325,650)	$ (20,215)	$ (256,226)
Shares, Outstanding at Mar. 31, 2020		40,271,411				14,169

XML

Subsequent Events - Additional Information (Details) - USD ($)	Apr. 17, 2020	May 15, 2019
Delayed Draw Facility
Subsequent Event [Line Items]
Debt instrument, face amount		$ 55,000,000.0
Revolving Loan Facility
Subsequent Event [Line Items]
Debt instrument, face amount		$ 35,000,000.0
Subsequent Event | New Credit Facility
Subsequent Event [Line Items]
Debt instrument, face amount	$ 165,000,000.0
Line of credit facility, maturity date	Apr. 17, 2025
Subsequent Event | Delayed Draw Facility
Subsequent Event [Line Items]
Debt instrument, face amount	$ 130,000,000.0
Subsequent Event | Revolving Loan Facility
Subsequent Event [Line Items]
Debt instrument, face amount	$ 35,000,000.0

XML

Net Loss Per Share Attributable to Common Shareholder - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Earnings Per Share [Abstract]
Adjustments between net loss and net loss attributable to common stockholders	$ 0	$ 0

XML

Equity Incentive Plans - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Nov. 30, 2014
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation	$ 2,241,847	$ 1,260,126
Service Period Stock Options | Chief Executive Officer and Executive Vice President of Finance
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	4 years
Performance-Vested Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Performance-vested stock options	1,303,361
Performance-vested stock options, weighted average exercise price	$ 18.50
2010 Stock Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock options, available for grant	0
Total number of unexercised options	256,890
2010 Stock Plan | Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	2 years
2010 Stock Plan | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	4 years
2014 Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock options, available for grant	1,457,834		2,644,133
2014 Omnibus Incentive Plan | Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total number of unexercised options	2,644,133
2014 Omnibus Incentive Plan | Restricted Stock Units | Employee
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	3 years
2014 Omnibus Incentive Plan | Restricted Stock Units | Non-employee Director
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	1 year

XML

Leases - Weighted Average Remaining Lease Term And Discount Rate Related To Operating Leases (Details)	Mar. 31, 2020
Leases [Abstract]
Weighted-average remaining lease term	5 years 11 months 26 days
Weighted-average discount rate	6.14%

XML

Property, Plant and Equipment - Additional Information (Details) - USD ($)	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Property, Plant and Equipment
Property Plant And Equipment [Line Items]
Depreciation expense	$ 4,372,792	$ 3,643,492
Product
Property Plant And Equipment [Line Items]
Cost of goods sold, depreciation and amortization	$ 1,743,657	$ 1,566,088

XML

Equity Incentive Plans

3 Months Ended

Mar. 31, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Equity Incentive Plans

Note 7 – Equity Incentive Plans:

Total compensation cost for share-based payments recognized for the three months ended March 31, 2020 and 2019 is $2,241,847 and $1,260,126, respectively.

2010 Stock Plan—The outstanding options are time-based (vest between two and four years). At March 31, 2020, there were zero shares available for grant as the 2010 Plan is frozen. The total number of unexercised options for the 2010 Plan is 256,890.

2014 Omnibus Incentive Plan—In November 2014, the Company approved the 2014 Omnibus Incentive Plan (the “2014 Plan”). Under the 2014 Plan, 2,644,133 shares of common stock may be issued or used for reference purposes as awards granted. These awards may be in the form of stock options, stock appreciation rights, restricted stock, as well as other stock-based and cash-based awards. At March 31, 2020, the awards granted were either time-based, performance-based (vest when performance targets are met, as defined in the stock option grant agreement), or restricted stock units (employee RSUs vest over three years or cliff vest (as defined in the restricted stock agreement) and non-employee director RSUs vest over one year). The total number of unexercised options and RSUs for the 2014 Plan is 2,644,133.

At March 31, 2020, there were 1,457,834 shares of common stock available to be issued or used for reference purposes under the 2014 Plan.

NASDAQ Marketplace Rules Inducement Award—During fiscal year 2016 and the first quarter of 2020, share-based awards were granted to the Company’s Chief Executive Officer and the Executive Vice President of Finance, respectively, as an inducement under the NASDAQ Marketplace Rules, and therefore outside of any Plan. Under the terms of the agreement, the grant is governed as if issued under the 2014 Omnibus Plan. As of March 31, 2020, the awards granted were time-based (cliff vest over four years) and performance-based (vest when performance targets are met, as defined in the stock option grant agreement).

Service Period Stock Options

The following table includes activity related to outstanding service period stock options during the three months ended March 31, 2020.

Service Period Stock Options	Shares			Weighted Average Exercise Price
Outstanding at December 31, 2019		1,359,990		$	11.50
Granted		15,000			60.10
Exercised		(44,156	)		9.11
Forfeited		(357	)		11.00
Outstanding at March 31, 2020		1,330,477		$	12.13

Performance-Vested Stock Options

The following table includes activity related to outstanding performance-vested stock options during the nine months ended March 31, 2020.

Performance Based Options	Shares		Weighted Average Exercise Price
Outstanding at December 31, 2019		1,372,819	$	18.31
Granted		—		—
Exercised		—		—
Forfeited		—		—
Outstanding at March 31, 2020		1,372,819	$	18.31

As of March 31, 2020, 1,303,361 performance-vested stock options at a weighted average exercise price of $18.50 have performance metrics that are probable of achievement. These shares are included in share-based compensation costs for the three months ended March 31, 2020.

Restricted Stock Units

The following table includes activity related to outstanding restricted stock units during the three months ended March 31, 2020.

Restricted Stock Units	Shares			Weighted-Average Grant-Date Fair Value Per Unit
Outstanding at December 31, 2019		240,229		$	29.07
Granted		5,280			62.88
Issued upon vesting		(32,727	)		17.56
Forfeited		(604	)		32.83
Outstanding at March 31, 2020		212,178		$	31.68

XML

Subsequent Events

3 Months Ended

Mar. 31, 2020

Subsequent Events [Abstract]

Subsequent Events

Note 11 – Subsequent Events:

The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued for recognitions or disclosures and no events have occurred that require disclosure, except for the following:

On April 17, 2020 the Company amended its  senior secured credit facility (the “New Credit Facility”). This New Credit Facility of $165.0 million, includes a $130.0 million delayed draw term loan facility and a $35.0 million revolving loan facility. The New Credit Facilities replaces the Company’s prior $55.0 million delayed draw term loan facility and $35.0 million revolving loan facility. The New Credit Facility will mature on April 17, 2025.

Based upon further evaluation, the Company did not identify any additional recognized or unrecognized subsequent events that have required adjustment or disclosure in the financial statements.

XML

CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Statement Of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	40,271,411	36,162,433
Common stock, shares outstanding	40,257,242	36,148,264
Treasury stock, at cost, shares	14,169	14,169

XML

Nature of the Business and Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Nature of the Business and Summary of Significant Accounting Policies

Note 1 – Nature of the Business and Summary of Significant Accounting Policies:

Nature of the Business – Freshpet, Inc. (hereafter referred to as “Freshpet” the “Company”, “we” or “our”), a Delaware corporation, manufactures and markets natural fresh meals and treats for dogs and cats. The Company’s products are distributed throughout the United States and other international markets, into major retail classes including Grocery (including online), Mass and Club, Pet Specialty, and Natural retail.

Basis of Presentation – The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”). The unaudited consolidated financial statements include the accounts of the Company as well as the Company’s wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The interim unaudited consolidated financial statements have been prepared on the same basis as the annual audited consolidated financial statements and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). In the opinion of management, the interim unaudited financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of March 31, 2020, the results of its operations and changes to stockholders’ equity for the three months ended March 31, 2020 and 2019, and its cash flows for the three months ended March 31, 2020 and 2019. The results for the three months ended March 31, 2020 are not necessarily indicative of results to be expected for the year ending December 31, 2020, or any other interim periods, or any future year or period. Certain amounts that appear in this report may not add up because of differences due to rounding.

These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes in Item 8 of Part II, “Financial Statements and Supplementary Data,” of our Annual Report on Form 10-K for the year ended December 31, 2019.

Estimates and Uncertainties – The preparation of our consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results, as determined at a later date, could differ from those estimates.

Fair Value of Financial Instruments – Financial Accounting Standards Board (“FASB”) guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).

The three levels of the fair value hierarchy are as follows:

• Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities.

• Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 2 includes financial instruments that are valued using models or other valuation methodologies.

• Level 3 – Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when their fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable.

The carrying amounts reported in the balance sheets for cash and cash equivalents, short-term investments, other receivables, accounts payable and accrued expenses approximate their fair value based on the short-term maturity of these instruments.

As of March 31, 2020, the Company only maintained Level 1 assets and liabilities.

Short-Term Investments – The Company holds interest-bearing certificates of deposits with financial institutions with maturities ranging from three months to one year. Certificates of deposit are classified as short-term investments and interest is recorded as other income.

Restricted Stock Tax Withholdings – To meet payroll tax withholdings obligations arising from the vesting of restricted share units, the Company withheld 10,077 shares totaling $0.7 million, for the three month period ended March 31, 2019. Shares of common stock withheld for tax withholdings do not reduce the Company’s total share repurchase authority.

Debt Issuance Cost – During 2019, the Company incurred $1.1 million of fees associated with the debt modification, of which $0.7 million were paid to the creditor. Further, the Company noted that $0.7 million of the fees were related to the Draw Term Loan with the remaining balance relating to the Revolving Loan Facility. The Company’s policy is to record the debt issuance cost related to the Draw Term Loan, net of debt, for the portion of the Draw Term Loan that is outstanding, with the remaining amount recorded within assets. As of March 31, 2020, the Company paid the outstanding balance of the Draw Term Loan and wrote down $0.6 million of the related fees. As of March 31, 2020, there was $0.5 million of debt issuance cost that were recorded to other assets and less than $0.1 million was recorded to other current assets.  

The Company amortizes debt issuance costs categorized as assets on a straight-line basis over the term of the loan, and amortizes the debt issuance costs that are categorized net of debt using the effective interest method, over the term of the loan.

Information about the Company’s net sales by class of retailer is as follows:

	Three Months Ended
	March 31,
	2020		2019
Grocery (including Online), Mass and Club	$	60,818,851	$	45,707,897
Pet Specialty and Natural		9,278,954		9,084,305
Net Sales	$	70,097,805	$	54,792,202

Recently Issued Accounting Standards

In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard requires an entity to utilize a new impairment model known as the current expected credit loss (“CECL”) model to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. The new guidance is effective for financial statements issued for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The reported results for the three months ended March 31, 2020 reflect the application of ASU 2016-13. The application of the update did not have a material impact to our reserve for accounts receivable. Please see the description of the Company’s “Trade accounts receivable” accounting policy below.

Trade accounts receivable – The allowance for doubtful accounts is based on the Company’s assessment of the collectability of customer accounts. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the accounts receivable balances and current economic conditions that may affect a customer’s ability to pay.

XML

Leases (Tables)

3 Months Ended

Mar. 31, 2020

Leases [Abstract]

Weighted Average Remaining Lease Term And Discount Rate Related To Operating Leases

Weighted-average remaining lease term (in years) and discount rate related to operating leases were as follows:

Weighted-average remaining lease term	5.99
Weighted-average discount rate	6.14	%

Maturities of Lease Liabilities Under Noncancelable Operating Leases

Maturities of lease liabilities under noncancellable operating leases as of March 31, 2020 were as follows:

	March 31, 2020
2020 (a)		1,319,802
2021		1,768,626
2022		1,763,787
2023		1,802,007
2024		1,511,214
2024 and beyond		2,786,004
Total lease payments		10,951,440
Less: Imputed interest		(1,641,112	)
Present value of lease liabilities	$	9,310,328

(a) Excluding the three months ended March 31, 2020.

Summary of Rent Expense

A summary of rent expense for the three months ended March 31, 2020 and 2019 was as follows:

	For the Three Months Ended
	March 31,
	2020		2019
Operating lease cost	$	452,155	$	256,882

Supplemental Cash Flow Information And Non-cash Activity Relating To Operating Leases

Supplemental cash flow information and non-cash activity relating to operating leases are as follows:

	For the Three Months Ended March 31,
	2020		2019
Operating cash flow information:
Cash paid for amounts included in the measurement of lease liabilities	$	283,982	$	246,735

XML

Nature of the Business and Summary of Significant Accounting Policies - Information About Company's Net Sales By Class of Retailer (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Net Sales	$ 70,097,805	$ 54,792,202
Grocery (including Online), Mass and Club
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Net Sales	60,818,851	45,707,897
Pet Specialty and Natural
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Net Sales	$ 9,278,954	$ 9,084,305

XML

Concentrations - Additional Information (Details)	Mar. 31, 2020 USD ($)
Maximum
Concentration Risk [Line Items]
Cash, FDIC insured amount	$ 250,000

XML

Nature of the Business and Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Information About Company's Net Sales By Class of Retailer

Information about the Company’s net sales by class of retailer is as follows:

	Three Months Ended
	March 31,
	2020		2019
Grocery (including Online), Mass and Club	$	60,818,851	$	45,707,897
Pet Specialty and Natural		9,278,954		9,084,305
Net Sales	$	70,097,805	$	54,792,202

XML

Debt

3 Months Ended

Mar. 31, 2020

Debt Disclosure [Abstract]

Debt

Note 5 – Debt:

On May 15, 2019, the Company entered into the Fourth Amended and Restated Loan and Security Agreement (as amended, the “Loan Agreement”), which amended and restated in full the Company’s Third Amended and Restated Loan and Security Agreement, dated as of September 21, 2017. The Loan Agreement provided for a $90 million senior secured credit facility (the “Credit Facility”), encompassing a $55.0 million delayed draw term loan facility (the “Draw Facility”) and a $35.0 million revolving loan facility (the “Revolving Loan Facility”). The Company had the ability to increase the Credit Facility by up to an additional $75.0 million, subject to certain conditions.

The Credit Facility was scheduled to mature on May 15, 2024 and borrowings thereunder accrued interest at variable rates depending on the Company’s election, either at a base rate or at LIBOR, in each case, plus an applicable margin. Subject to the Company’s leverage ratio, the applicable margin varied between 0.50% and 1.00% for base rate loans and 1.50% and 2.00% for LIBOR loans. Upon closing the Credit Facility, the Company borrowed $15.0 million under the Revolving Loan Facility, which left $20.0 million of availability. The Company had the option to borrow term loans under the Draw Facility (“Draw Term Loans”) until May 15, 2021, subject to certain conditions.

Borrowings under the Credit Facility were secured by substantially all of the Company’s and certain of its subsidiaries’ assets. The Loan Agreement required compliance with various covenants customary for agreements of this type, including financial covenants and negative covenants that limit, among other things, the Company’s ability to incur additional debt, create or incur liens, engage in mergers or consolidations, sell, transfer or otherwise dispose of assets, make voluntary prepayments to subordinated debt, permit a change of control, pay dividends or distributions, make investments, and enter into certain transactions with affiliates. The Loan Agreement also included events of default customary for agreements of this type.

As of March 31, 2020, the Company had no debt outstanding under the Credit Facilities. During the first quarter of 2020, borrowings under the Credit Facilities totaled $20.9 million that consisted of $13.9 million related to Draw Term Loans, net of unamortized debt issuance cost of less than $0.1 million, and $7.0 million related to the Revolving Loan Facility. Net borrowings under the Credit Facilities totaled $54.5 million at December 31, 2019, of which $40.5 million net of unamortized debt issuance cost of $0.6 million, related to the Draw Term Loans and $14.0 million related to the Revolving Loan Facility.

Interest expense and fees totaled $0.7 million for the three months ended March 31, 2020, of which $0.6 million was related to the recognition of debt issuance fees due to the repayment of the Draw Term Loan. Interest expense and fees totaled $0.1 million for the three months ended March 31, 2019.

In 2019, the Company incurred $1.1 million of debt issuance cost upon execution of the Credit Facility. As of March 31, 2020, the Company paid the outstanding balance of the Draw Term Loan and wrote down $0.6 million of the related debt

issuance fees that were recognized as interest expense. As of March 31, 2020, $0.5 million of the remaining debt issuance cost was recorded to other assets and less than $0.1 million was recorded to other current assets.

XML

Concentrations

3 Months Ended

Mar. 31, 2020

Risks And Uncertainties [Abstract]

Concentrations

Note 9 – Concentrations:

Concentration of Credit Risk—The Company maintains its cash balances in financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 each. At times, such balances may be in excess of the FDIC insurance limit.

XML

Leases - Summary of Rent Expense (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases [Abstract]
Operating lease cost	$ 452,155	$ 256,882

XML

Debt - Additional Information (Details) - USD ($)		3 Months Ended		12 Months Ended
	May 15, 2019	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Debt Instrument [Line Items]
Borrowings under credit facilities		$ 20,933,000	$ 10,000,000
Debt outstanding under credit facilities		0
Debt outstanding		20,900,000		$ 54,500,000
Unamortized debt issuance cost				600,000
Interest expense and fees		700,000	$ 100,000
Other Assets
Debt Instrument [Line Items]
Financing costs capitalized		500,000
Term Loans
Debt Instrument [Line Items]
Debt outstanding		13,900,000		40,500,000
Amortization of debt issuance costs		600,000
Revolving Loan
Debt Instrument [Line Items]
Debt outstanding		7,000,000.0		14,000,000.0
Maximum
Debt Instrument [Line Items]
Unamortized debt issuance cost		100,000
Maximum | Other Current Assets
Debt Instrument [Line Items]
Financing costs capitalized		100,000
Credit Facility
Debt Instrument [Line Items]
Debt instrument, face amount	$ 90,000,000
Line of credit facility, maturity date	May 15, 2024
Amortization of debt issuance costs				$ 1,100,000
Credit Facility | Term Loans
Debt Instrument [Line Items]
Amortization of debt issuance costs		600,000
Credit Facility | Term Loans | Other Assets
Debt Instrument [Line Items]
Financing costs capitalized		500,000
Credit Facility | Maximum
Debt Instrument [Line Items]
Increase in credit facility	$ 75,000,000.0
Credit Facility | Maximum | Term Loans | Other Current Assets
Debt Instrument [Line Items]
Financing costs capitalized		$ 100,000
Credit Facility | Maximum | Base Rate
Debt Instrument [Line Items]
Line of credit facility, applicable margin	1.00%
Credit Facility | Maximum | LIBOR
Debt Instrument [Line Items]
Line of credit facility, applicable margin	2.00%
Credit Facility | Minimum | Base Rate
Debt Instrument [Line Items]
Line of credit facility, applicable margin	0.50%
Credit Facility | Minimum | LIBOR
Debt Instrument [Line Items]
Line of credit facility, applicable margin	1.50%
Delayed Draw Facility
Debt Instrument [Line Items]
Debt instrument, face amount	$ 55,000,000.0
Revolving Loan Facility
Debt Instrument [Line Items]
Debt instrument, face amount	35,000,000.0
Borrowings under credit facilities	15,000,000.0
Line of credit facility, remaining borrowing capacity	$ 20,000,000.0

XML

Accrued Expenses

3 Months Ended

Mar. 31, 2020

Payables And Accruals [Abstract]

Accrued Expenses

Note 4 – Accrued Expenses:

	March 31,		December 31,
	2020		2019
Legal Contingency (1)		10,310,000		10,100,000
Accrued Compensation and Employee Related Costs		4,033,898		6,390,692
Accrued Chiller Cost		1,548,752		1,576,214
Accrued Customer Consideration		735,172		635,399
Accrued Freight		726,381		702,673
Accrued Production Expenses		1,801,527		413,550
Accrued Marketing		595,376		1,187,885
Other Accrued Expenses		689,362		1,126,515
	$	20,440,468	$	22,132,928

(1) See Note 10 for additional information.

XML

Net Loss Per Share Attributable to Common Shareholder

3 Months Ended

Mar. 31, 2020

Earnings Per Share [Abstract]

Net Loss Per Share Attributable to Common Shareholder

Note 8 – Net Loss Per Share Attributable to Common Shareholder:

Basic net loss per share of common stock is calculated by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. Diluted net loss per share of common stock is computed by giving effect to all potentially dilutive securities.

For the three months ended March 31, 2020 and 2019, there were no adjustments between net loss and net loss attributable to common stockholders.

The potentially dilutive securities are as follows:

	Three Months Ended
	March 31,
	2020		2019
Service Period Stock Options		1,355,853		1,686,048
Restricted Stock Units		241,582		249,252
Performance Stock Options		34,482		59,693
Total		1,631,917		1,994,993

For the three months ended March 31, 2020 and 2019, diluted net loss per share of common stock is the same as basic net loss per share of common stock, due to the fact that potentially dilutive securities would have an antidilutive effect as the Company incurred a net loss during such periods.

XML

Nature of the Business and Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Nature of the Business

Nature of the Business – Freshpet, Inc. (hereafter referred to as “Freshpet” the “Company”, “we” or “our”), a Delaware corporation, manufactures and markets natural fresh meals and treats for dogs and cats. The Company’s products are distributed throughout the United States and other international markets, into major retail classes including Grocery (including online), Mass and Club, Pet Specialty, and Natural retail.

Basis of Presentation

Basis of Presentation – The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”). The unaudited consolidated financial statements include the accounts of the Company as well as the Company’s wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The interim unaudited consolidated financial statements have been prepared on the same basis as the annual audited consolidated financial statements and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). In the opinion of management, the interim unaudited financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of March 31, 2020, the results of its operations and changes to stockholders’ equity for the three months ended March 31, 2020 and 2019, and its cash flows for the three months ended March 31, 2020 and 2019. The results for the three months ended March 31, 2020 are not necessarily indicative of results to be expected for the year ending December 31, 2020, or any other interim periods, or any future year or period. Certain amounts that appear in this report may not add up because of differences due to rounding.

These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes in Item 8 of Part II, “Financial Statements and Supplementary Data,” of our Annual Report on Form 10-K for the year ended December 31, 2019.

Estimates and Uncertainties

Estimates and Uncertainties – The preparation of our consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results, as determined at a later date, could differ from those estimates.

Fair Value of Financial Instruments – Financial Accounting Standards Board (“FASB”) guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).

The three levels of the fair value hierarchy are as follows:

• Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities.

• Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 2 includes financial instruments that are valued using models or other valuation methodologies.

• Level 3 – Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when their fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable.

The carrying amounts reported in the balance sheets for cash and cash equivalents, short-term investments, other receivables, accounts payable and accrued expenses approximate their fair value based on the short-term maturity of these instruments.

As of March 31, 2020, the Company only maintained Level 1 assets and liabilities.

Short-Term Investments – The Company holds interest-bearing certificates of deposits with financial institutions with maturities ranging from three months to one year. Certificates of deposit are classified as short-term investments and interest is recorded as other income.

Restricted Stock Tax Withholdings – To meet payroll tax withholdings obligations arising from the vesting of restricted share units, the Company withheld 10,077 shares totaling $0.7 million, for the three month period ended March 31, 2019. Shares of common stock withheld for tax withholdings do not reduce the Company’s total share repurchase authority.

Debt Issuance Cost – During 2019, the Company incurred $1.1 million of fees associated with the debt modification, of which $0.7 million were paid to the creditor. Further, the Company noted that $0.7 million of the fees were related to the Draw Term Loan with the remaining balance relating to the Revolving Loan Facility. The Company’s policy is to record the debt issuance cost related to the Draw Term Loan, net of debt, for the portion of the Draw Term Loan that is outstanding, with the remaining amount recorded within assets. As of March 31, 2020, the Company paid the outstanding balance of the Draw Term Loan and wrote down $0.6 million of the related fees. As of March 31, 2020, there was $0.5 million of debt issuance cost that were recorded to other assets and less than $0.1 million was recorded to other current assets.  

The Company amortizes debt issuance costs categorized as assets on a straight-line basis over the term of the loan, and amortizes the debt issuance costs that are categorized net of debt using the effective interest method, over the term of the loan.

Information about the Company’s net sales by class of retailer is as follows:

	Three Months Ended
	March 31,
	2020		2019
Grocery (including Online), Mass and Club	$	60,818,851	$	45,707,897
Pet Specialty and Natural		9,278,954		9,084,305
Net Sales	$	70,097,805	$	54,792,202

Recently Issued Accounting Standards

Recently Issued Accounting Standards

In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard requires an entity to utilize a new impairment model known as the current expected credit loss (“CECL”) model to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. The new guidance is effective for financial statements issued for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The reported results for the three months ended March 31, 2020 reflect the application of ASU 2016-13. The application of the update did not have a material impact to our reserve for accounts receivable. Please see the description of the Company’s “Trade accounts receivable” accounting policy below.

Trade accounts receivable – The allowance for doubtful accounts is based on the Company’s assessment of the collectability of customer accounts. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the accounts receivable balances and current economic conditions that may affect a customer’s ability to pay.

XML

Leases - Supplemental Cash Flow Information And Non-cash Activity Relating To Operating Leases (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating cash flow information:
Cash paid for amounts included in the measurement of lease liabilities	$ 283,982	$ 246,735

XML

Leases - Additional Information (Details)	3 Months Ended
	Mar. 31, 2020
Lessee Lease Description [Line Items]
Operating lease, renewal term	5 years
Operating lease, existence of option to extend	true
Minimum
Lessee Lease Description [Line Items]
Operating lease remaining lease term	2 years
Maximum
Lessee Lease Description [Line Items]
Operating lease remaining lease term	9 years

XML

CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)		Mar. 31, 2020	Dec. 31, 2019
CURRENT ASSETS:
Cash and cash equivalents		$ 149,486,159	$ 9,471,676
Short-term investments		20,000,000
Accounts receivable, net of allowance for doubtful accounts		20,295,397	18,580,840
Inventories, net		16,005,370	12,542,269
Prepaid expenses		2,998,336	3,275,992
Other current assets(1)	[1]	10,720,781	10,452,990
Total Current Assets		219,506,043	54,323,767
Property, plant and equipment, net		195,607,774	165,287,597
Deposits on equipment		4,298,520	3,600,931
Operating lease right of use assets		8,846,194	9,154,234
Other assets		3,708,158	3,759,058
Total Assets		431,966,689	236,125,587
CURRENT LIABILITIES:
Accounts payable		20,420,592	18,667,729
Accrued expenses(1)	[1]	20,440,468	22,132,928
Current operating lease liabilities		1,241,168	1,185,058
Total Current Liabilities		42,102,228	41,985,715
Long term debt			54,466,099
Long term operating lease liabilities		8,069,160	8,409,252
Total Liabilities		50,171,388	104,861,066
STOCKHOLDERS' EQUITY:
Common stock — voting, $0.001 par value, 200,000,000 shares authorized, 40,271,411 issued and 40,257,242 outstanding on March 31, 2020, and 36,162,433 issued and 36,148,264 outstanding on December 31, 2019		40,271	36,162
Additional paid-in capital		588,357,121	334,299,172
Accumulated deficit		(206,325,650)	(202,735,417)
Accumulated other comprehensive income		(20,215)	(79,170)
Treasury stock, at cost — 14,169 shares on March 31, 2020 and on December 31, 2019		(256,226)	(256,226)
Total Stockholders' Equity		381,795,301	131,264,521
Total Liabilities and Stockholders' Equity		$ 431,966,689	$ 236,125,587

[1] See Note 10 for additional information.

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (3,590,233)	$ (3,422,000)
Adjustments to reconcile net loss to net cash flows provided by operating activities:
Provision for loss/(gains) on accounts receivable	90,712	28,778
Loss on disposal of equipment	1,662	8,028
Share-based compensation	2,178,214	1,200,336
Inventory obsolescence	117,937	10,238
Depreciation and amortization	4,453,031	3,720,091
Amortization of deferred financing costs and loan discount	625,299	28,775
Changes in operating assets and liabilities:
Accounts receivable	(1,805,269)	(5,010,252)
Inventories	(3,581,038)	(1,802,222)
Prepaid expenses and other current assets	9,865	(929,849)
Operating lease right of use	308,040	241,785
Other assets	11,786	(36,010)
Accounts payable	655,688	2,555,681
Accrued expenses	(1,692,460)	(832,986)
Other lease liabilities	(283,982)	(217,469)
Net cash flows used in operating activities	(2,500,748)	(4,457,076)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of short-term investments	(20,000,000)
Acquisitions of property, plant and equipment, software and deposits on equipment	(34,237,980)	(10,453,923)
Net cash flows used in investing activities	(54,237,980)	(10,453,923)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from common shares issued in primary offering, net of issuance cost	252,062,254
Proceeds from exercise of options to purchase common stock	402,556	1,791,668
Tax withholdings related to net shares settlements of restricted stock units	(644,599)	(673,774)
Proceeds from borrowings under Credit Facilities	20,933,000	10,000,000
Repayment of borrowings under Credit Facilities	(76,000,000)
Net cash flows provided by financing activities	196,753,211	11,117,894
NET CHANGE IN CASH AND CASH EQUIVALENTS	140,014,483	(3,793,105)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	9,471,676	7,554,388
CASH AND CASH EQUIVALENTS, END OF PERIOD	149,486,159	3,761,283
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	766,950	29,717
NON-CASH FINANCING AND INVESTING ACTIVITIES:
Property, plant and equipment purchases in accounts payable	$ 8,671,690	463,546
Non-cash acquisitions of property, plant and equipment		$ 1,749,901

XML

Accrued Expenses (Tables)

3 Months Ended

Mar. 31, 2020

Payables And Accruals [Abstract]

Summary of Accrued Expenses

	March 31,		December 31,
	2020		2019
Legal Contingency (1)		10,310,000		10,100,000
Accrued Compensation and Employee Related Costs		4,033,898		6,390,692
Accrued Chiller Cost		1,548,752		1,576,214
Accrued Customer Consideration		735,172		635,399
Accrued Freight		726,381		702,673
Accrued Production Expenses		1,801,527		413,550
Accrued Marketing		595,376		1,187,885
Other Accrued Expenses		689,362		1,126,515
	$	20,440,468	$	22,132,928

(1) See Note 10 for additional information.

XML

Nature of the Business and Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Payments related to tax withholding for share-based compensation	$ 644,599	$ 673,774
Shares paid for tax withholding for share based compensation		10,077
Fees associated with debt modification			$ 1,100,000
Term Loans
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Debt issuance fees write off	600,000
Revolving Credit Facility
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Payment of fees associated with debt modification			700,000
Other Assets
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Debt issuance cost recorded as net of debt outstanding	500,000
Maximum | Other Current Assets
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Debt issuance cost recorded as net of debt outstanding	$ 100,000
Creditor
Nature Of Business And Summary Of Significant Accounting Policies [Line Items]
Payment of fees associated with debt modification			$ 700,000

XML

Commitments and Contingencies - Additional Information (Details) - USD ($)	Mar. 11, 2020	Mar. 31, 2020	Dec. 31, 2019
Commitments And Contingencies [Line Items]
Legal Contingency		$ 10,310,000	$ 10,100,000
Curran v. Freshpet, Inc.
Commitments And Contingencies [Line Items]
Legal Contingency		10,100,000
Option to appeal period	30 days
Curran v. Freshpet, Inc. | Other Current Assets
Commitments And Contingencies [Line Items]
Gain Contingency		10,100,000
Meldon v. Freshpet, Inc. | Pending Litigation
Commitments And Contingencies [Line Items]
Legal Contingency		200,000
Meldon v. Freshpet, Inc. | Other Current Assets | Pending Litigation
Commitments And Contingencies [Line Items]
Gain Contingency		$ 200,000